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resumo 
 
 
A estimativa do tempo de morte de um cadáver é uma parte absolutamente 
crucial de muitos casos forense. Um posicionamento preciso no tempo na 
sequência de eventos de um caso é uma informação que pode criar uma 
lista de suspeitos ou isentar suspeitos, alterando profundamente um caso 
inteiro. Atualmente, o intervalo postmortem e a hora da morte são 
avaliados por meio de várias avaliações físicas, metabólicas e físico-
químicas durante a autópsia. Essas avaliações trazem pontos fortes, fracos 
e variações, e um procedimento mais estável e robusto seria inestimável 
para o avanço das ciências forenses. Um dos focos mais recentes para esse 
possível procedimento baseia-se numa das regulações epigenéticas do 
DNA, a adição de um grupo metilo a certas citosinas, conhecido como 
metilação do DNA. A metilação do DNA regula muitos aspetos do 
genoma, desde o silenciamento de genes expressos só em alguns tecidos, 
seções não codificantes do DNA, até a especialização de tecidos e uma 
resposta estável a longo prazo a estímulos do ambiente. Este trabalho é 
uma revisão sobre procedimentos, possíveis biomarcadores, possíveis 
variáveis e obstáculos no uso desta modificação regulatória do 
consideravelmente estável postmortem DNA. 
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Abstract 
 
Estimation of a corpse’s time of death is an absolute crucial part of many 
forensic cases. An accurate time placement in a case’s sequence of events 
is information that can create a suspect list or exempt suspects from it, 
deeply altering an entire case. Currently, postmortem intervals and time of 
death is assessed through several physical, metabolic and physiochemical 
evaluations during autopsy. These evaluations carry strengths, 
weaknesses and variations, and a more stable and robust procedure would 
be invaluable to the advancement of forensic sciences. One of the most 
recent focus for such a possible procedure relies in one of the epigenetic 
regulations of DNA, the addition of a methyl group to certain cytosines, 
known as DNA methylation. DNA methylation regulates many aspects of 
the genome, from silencing tissue specific genes, non-coding sections of 
DNA, up to tissue specialization and working as a stable long-term 
response to the environment. This work is a review on procedures, 
potential biomarkers, possible viability and obstacles in the way of using 
this regulatory modification of the considerably stable port-mortem DNA. 
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1. Forensic Sciences, an Introduction 
 
Forensic science is a broad term applied to any and all science which is accepted by 
legal standards that can be used in criminal investigation in order to uphold the perpetrator 
accountable to the established criminal and civil law and current legislation. 
The term forensic derives from a form roman trial [1] that when a dispute or criminal 
charge would be made, defense and prosecution would be presented to several individuals 
in the roman forums, giving the word its meaning of “pertaining to the forum” [2]. While 
romans had a strong judicial system, laws and enforcement bodies, one of the first written 
books on how to use medicine and entomology to help with crime solving, effectively being 
one of the first published forensic books, was Xǐ-yuān lù or Collected Writings on the 
Washing Away of Wrongs, written by Song Ci, during the reign of Shun Yu, in 1247 [3] (Fig. 
1). 
 
 
While currently being a wide and encompassing field of study, in early human 
history, forensic sciences have been unreliable and often misused. In early criminal 
investigations and trials, confession and witness testimony were the most used methods of 
enforcing accountability, often leading to dubious results due to confessions being forced 
and witnesses unreliable.  
Fig. 1- A sample of Xǐ-yuān lù, detailing the human skeleton and its nomenclature, present 
in Sòng Cí: Xǐ-yuān lù jí-zhèng. Adapted from 
https://upload.wikimedia.org/wikipedia/commons/thumb/1/18/Xiyuanlu_jizheng-1843-
Bones.jpg/330px-Xiyuanlu_jizheng-1843-Bones.jpg 
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In more recent times, several fields of forensic sciences have been well defined. 
Thanatology, from the Greek word Thanatos, meaning death or god of death in mythology 
[4], is the study of death and how the body and others are affected by it [5]. Forensic 
thanatology on the other hand is the study of every phenomenon cause by death through 
postmortem examination [6]. It encompasses the medico-legal autopsy, a form of specialized 
autopsy realized by a pathologist qualified in forensic pathology done with the intent of 
finding and registering any and all injuries in detail, so that they may be used in the court of 
law [7], on top of the regular objectives of a clinical autopsy. A medico-legal autopsy also 
has as objectives the identification of the body, the estimation of the time of death, the 
determination of the relevance of each injury to the cause of death, the prior presence of 
disease and its effects on the body, toxin and poison screening and presence of effects 
lingering from prior medical surgeries or interventions [7]. The amount of information about 
a case that can be acquired through a medico-legal autopsy is large, but it is limited in the 
scope of time available, because as more time passes, the finer details may be lost. 
Another area of expertise that are used to glean information about the case on a bigger 
time frame is forensic entomology [8]. Whenever a body dies, in nature, it becomes a bounty 
of easy food, ripe for the taking. Allured by such an opportunity, a great variety of animals 
flock to the scene, most being scavengers, bacteria, fungi, with necrophagous insects being 
the most prominent, both in number and forensic importance [8]. Many of the insect species 
that gorge themselves in the decaying flesh also breed on it, and the timings of their life 
cycle and knowledge of the times taken for the species to settle in a body can be used to 
calculate the age of a body. Not only that but some of the species are only native to certain 
environments and habitats, causing their presence in a body found in a foreign area to the 
species to denounce the movement of the body postmortem [8]. 
Unfortunately, there will be cases where the body will not be found for many, many 
years, or even decades. By then, naught but the skeleton and hard objects like metal 
belongings of the victim may remain in its resting place. In these cases, the aid of forensic 
anthropology is required. Forensic anthropology encompasses several fields of study, such 
as anatomy, anthropology, archeology to some extent, and shares many points of interest 
with odontologists [9]. Forensic anthropologists work with remains that have almost to none 
flesh, such as skeletons, fully decomposed bodies and burnt to carbonized remains, to name 
a few [9], in order to provide those remains an identification, be it of ancestry, sex, age, both 
at time of death and current age, or all combined [9], information necessary for a criminal 
case. This is achieved through extensive knowledge of the morphology of the human 
skeleton and the dysmorphisms it exhibits between diverse ages, ancestries and both sexes.  
These three fields of forensic sciences are used in conjunction with each other and 
many others to obtain several distinct bits of information about the case but all three can 
provide the very crucial and critical time of death and the time passed between its occurrence 
and the discovery, the postmortem interval. 
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1.1. Postmortem Intervals  
 
Postmortem intervals refer to the time transpired between an organism’s death and 
the time of its discovery. It’s a critical piece of information necessary for the creation of a 
solid forensic analysis of a case, without which a case might go unsolved due to the 
impossibility of placing victim and perpetrator in the crime scene at the same time without 
reasonable doubt. Current techniques and tactics used to determine a PMI can range from 
social fields like time and location of last phone calls and text messages sent by the victim 
and passerby witness sightings to thanatological findings like body temperature and rigor 
mortis to more experimental protocols in development such as mRNA degradation [10], 
[11].  
Most of these techniques are based on the effects of death on the body. Upon the 
irreversible cessation of the heartbeat, several changes start happening to the organism. 
Without blood being pumped and the onset of hypoxia beginning, cells begin to sustain 
themselves through anoxic metabolic pathways, until reserves are depleted and cell death 
ensues [7]. At a macro level, quickly after death the termination of circulation drains the 
blood from capillaries, creating a paleness called pallor mortis (Fig. 2) [12], setting in 
between fifteen to twenty minutes, and muscles lose all tone, signaling the primary 
flaccidity, but still staying  responsive to internal and external stimuli [7].  
 
 
Fig. 2- Example of pallor mortis, denoted by the pallidity of the skin. Adapted from 
“http://www.doctoralerts.com/wp-content/uploads/2017/03/Pallor-Mortis.jpg” 
 
Following the primary flaccidity, muscle cells start building up lactic acid as a sub-product 
of the anoxic pathways, and in conjunction with low levels of ATP in the cell, the myosin 
fibers and the actin bind together, creating rigid structures, turning the muscles stiff, 
signaling the onset of rigor mortis (Fig. 3) [7]. The onset of rigor mortis occurs by stages, 
being noticed between one to four hours in the face and three to six hours in the limbs, 
reaching peak strength at eighteen hours, and once fully set, lasts for fifty hours [7].  
4 
 
 
 
Fig. 3- Example of rigor mortis, right foot not touching the ground defying gravity due to 
onset of stiffness. Adapted from “https://www.semanticscholar.org/paper/Rigor-mortis-in-
an-unusual-position%3A-Forensic-D%E2%80%99Souza-
Harish/fbe0653e31dbd1c230ea0d7726e8e87640e60a79/figure/1” 
 
During these stages, livor mortis and algor mortis are also taking effect. Livor mortis, or 
postmortem hypostasis refers to the settling of blood to the bottom of the organism of 
whatever position it may be in, due to gravity and lack of agitation (Fig. 4) [13]. It starts to 
settle immediately upon death, with early visible signs of discoloration on the superior part 
and reddening of the inferior part starting to appear by the hour mark, being fully visible 
from two to four hours after death, stage during which external pressure will still cause 
blanching, and will be fully fixated by the nine to twelve hour mark [13].  
 
 
Fig. 4- Example of livor mortis settling in, as blood drains to the bottom of the body. 
Adapted from “https://www.semanticscholar.org/paper/Early-post-mortem-changes-and-
stages-of-in-exposed-Goff/67107f4441924394c376c198800bf49357dbc23f/figure/1” 
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Algor mortis pertains to the cooling of the body. As cells switch to anoxic pathways, the 
body loses the capacity to regulate its own temperature, and as the laws of thermodynamics 
state, a warm object in contact with a cooler one will transfer its energy until balance is 
achieved. As such, a body will eventually reach the temperature of its environment [7]. On 
a general case, this will take up to eighteen to twenty hours, becoming unreliable past such 
interval [13]. After these stages, putrefaction and decomposition start. The exact form differs 
between the environment and temperature body lays in. Under water, putrefaction occurs 
much slower than bodies present in open air [7] and may suffer saponification, a process of 
anaerobic hydrolysis of the fatty tissue (Fig. 5) [13]. 
 
 
Fig. 5- A body that underwent saponification. Adapted from 
“https://www.semanticscholar.org/paper/Early-adipocere-formation%3A-a-case-report-
and-review-Kumar-Monteiro/f5387caf2c343b39ba9f1342bc0610a7b0832455/figure/0” 
 
Under dry environments, a body may suffer mummification, turning the skin dry and 
leathery-like (Fig. 6) [7].  
 
 
Fig. 6- Mummy of Ötzi the Iceman, a 3000-year-old naturally preserved mummy by the 
dry, icy conditions of the Similaun mountain. Adapted from 
“https://media.nbcdfw.com/images/653*367/72125418.jpg” 
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A combination of these markers can be used to calculate the time of death, and PMI, in cases 
of early body recovery, but in cases of periods larger than hours or days, whenever 
putrefaction and decomposition have settled in, the assessments starts to become ranges of 
possible PMIs, and the work of forensic entomologists may help greatly to refine the 
possibilities [7]. Their results are also obtained in ranges of possible PMIs, and the overlap 
is the key to such refinement.  
Yet, for such a vital necessity, the field techniques or thanatological assessments 
sustain variations in sensitivity due to several factors such as the temperature, the regional 
climate, local humidity, depth of burial, exposure to the elements and animals, body weight, 
etc. [14], suffering greater and greater deviations and errors as time passes. Laboratorial 
analysis may be able to avoid these variables or take them into account when determining 
the PMI. Ideally, and most times required by court to assure validity, a battery of reliable 
PMI assessing techniques based on physical, metabolic, bacterial, physiochemical, and now, 
genetic processes with enough well researched values, means and confidence limits should 
be used in order to combat each techniques’ shortcomings. With RNA degradation already 
under study to potentially be applied as a PMI estimator [10], [15], [16], the degradation of 
the epigenetic code of the DNA is another possible route of study. 
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2. Genetics and Epigenetics 
 
Deoxyribonucleic acid, or DNA, is the basis for which cells rely on to store nearly 
all the critical genetic information necessary for the entirety of its mechanisms. It is a 
complex double helix chain macromolecule composed of a large sequence of 4 nucleotides: 
the purines guanine and adenine and the pyrimidines cytosine and thymine, in a myriad of 
combinations, strung together through phosphodiester bonds created by the phosphate 
groups present in the 2-deoxyribose sugar residue backbone present in all of the 4 
nucleotides [17]. These nucleotides are themselves the basis for the genetic code. After 
transcription and during translation, sets of 3 nucleotides, with thymine being substituted 
with uracil in mRNA, are read by the ribosome as codons, which are correspondent to an 
amino acid to be added to the extending protein chain [18]. These sets of nucleotides that 
are to be translated into functional proteins through transcription and translation are stored 
within genes in the DNA, which are subjected to many forms of regulations. Upstream of 
the open reading frame (ORF), the promoter region which is necessary for gene expression 
exists [19]. It’s a region that is divided into 2 sections, the core promoter directly upstream 
of the ORF and the proximal promoter directly upstream of the core promoter. The core 
promoter is a critical structure for gene expression, being recognized by general transcription 
factors, regulatory proteins that are absolutely required for gene expression, and it is a 
binding site for RNA polymerase I, which transcribes rRNA precursors, RNA polymerase 
II, which transcribes mRNA, snRNA and miRNA, and RNA polymerase III, which  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7- A simplified flowchart from DNA information to protein, depicting cis-regulatory 
elements present is the gene structure such as the promoters, enhancers and silencers (top 
section), a pre-mRNA containing introns before being excised and lacking 5’cap and Poly-
A tail (middle section), a fully matured mRNA without introns and protected by the 5’cap 
and Poly-A tail (bottom section) and a fully folded, functional protein (red circle). Adapted 
from T. Shafee and R. Lowe, “Eukaryotic and prokaryotic gene structure” vol. 4, no. 1, pp. 
0–3, 2017. 
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transcribes tRNA and 5S rRNA [20]. RNA Polymerase II is a protein complex with 12 
subunits whose binding to the DNA molecule is mediated by the presence of TATA binding 
protein (TBP), a TFIID subunit, that once bound to the promoter recruits TFIIB, which in 
turn helps the Polymerase II complex (RNA polymerase II and TFIIF) bind properly to the 
promoter. Once this happens, TFIIE and TFIIH bind to the complex and form the 
transcription preinitiation complex. This complex is now capable of unwinding and  melting 
the double helix, point where the RNA Polymerase is capable of initiating elongations and 
all but TFIID leave the complex [21]. The proximal promoter is the area of the promoter that 
houses the specific transcription factor binding sites, responsible for the regulation of the 
affinity of the core promoter to the RNA Polymerases (Fig. 7). 
Epigenetics pertain to a group of modifications made to the nucleotides and histones, 
affecting the overall structure and condensation of the DNA double helix. These 
modifications serve as another layer of genetic regulation on top of all molecules that affect 
the binding of the RNA polymerases to the promoters, and their binding affinity. Epigenetic 
processes are responsible for a wide array of important phenomena such as genomic 
imprinting, inactivation of the X chromosome and several tumor suppressing regulations 
[22] and also act as the long term response to environmental pressures and stresses suffered 
over a large period of time [23]. The epigenetic code is highly sensitive and susceptible to 
these changes and can act as a genetic fingerprint on top of the already discriminatory DNA, 
with enough discerning power to distinguish even monozygotic twins, who share the same 
genetic information and very similar environments for most of their early life and yet end up 
with noticeable differences [24]. 
 
2.1. Epigenetics: DNA Methylation 
 
DNA methylation is a regulatory process where a methyl group is attached to, 
primarily, cytosine residues, although small amounts of cytosine hydroxymethylation and 
adenine methylation in certain unicellular eukaryotes can also be found. The process of DNA 
methylation is carried out by the DNA Methyltransferases enzyme family (DNMT), 
consisting of three core proteins: DNMT1, DNMT3a and DNMT3b.  
Throughout the entirety of an organism’s life, DNA methylation is kept as a 
housekeeping process. During the S phase of cell division [25], the phase on which DNA 
replication occurs, DNMT1 is recruited to the DNA replication sites through interactions 
with proliferating cell nuclear antigen and UHRF1. This mechanism is usually enough to 
maintain all imprinted DNA methylation. DNMT1 has higher affinity for hemi-methylated 
DNA [26], [27],  being bound to new DNA strands during replication, which are constituted 
by a methylated template strand and an unmethylated nascent strand. The requirement of a 
partially methylated DNA molecule to use as a template highly reduces DNMT1’s 
effectiveness as a de novo methyltransferase. When a complete DNA methylation wipe 
occurs, during gametogenesis and just before embryonic specification in the blastocyst, the 
de novo capable methyltransferases DNMT3a and DMNT3b are recruited instead. DNMT3b 
has been linked to earlier stages of embryo development and germline activity and DNMT3a 
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to later stages and post birth [27], maintaining and remaking the DNA methylation pattern 
during those stages. Without a template strand to guide the methylation, DNMT3 a and 
DNMT3b require regulation and support to prevent deviant methylation and correctly 
maintain repressed promoters. This help comes from many sources, one of them being the 
histone methyltransferases, enzymes responsible for the other facet of epigenetic regulation, 
histone methylation, acetylation, phosphorylation, and ubiquitination. These enzymes are 
named based on their function, starting by the kind of histone they act upon (H X), the base 
they act upon citing both residue and position and the number of methyl groups attached. 
CpG locations on or near transcription start sites are generally protected from DNMT3a and 
DNMT3b activity by the presence and activity of the transcription factor, H3K4 
methyltransferases, the CXXC finger protein 1 (CFP1), also known as CpG-binding protein, 
CpG binding protein 1 and DNA demethylation related enzymes such as TET enzymes or 
thymidine DNA glycosylase (Fig. 8)[25]. Promoters that do require silencing are done so 
after transcription, starting with the recruitment of LSH, a chromatin remodeling enzyme. 
Afterwards, Linker histone H1, H3K9 methyltransferases, heterochromatin protein 1 which 
are proteins with high binding affinity to nucleosomes containing histone H3 methylated at 
lysine K9, and the de novo DNA methyltransferases are recruited into the area, in that order 
[25]. In germline de novo methylation, DNMT3b acts after repression factors like 
Transcription factor E2F6 are recruited to the site. Two other DNMT proteins exist, DNMT2 
and DNMT3L, that do not function as cytosine methyltransferases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8- Transcription start site’s CpG site protection mechanisms. TF: Transcription Factor; 
TET: Ten-eleven Translocation enzyme; TDG: Thymine-DNA Glycosylase; SET1A: 
SET Domain Containing 1A Histone Lysine Methyltransferase; CFP1: CpG-binding 
protein (a). De novo methylation mechanism at promoters that are to be silenced. G9A 
is a H3K9 methyltransferase with GLP being an associated protein (b). Adapted from 
“Z. D. Smith and A. Meissner, “DNA methylation: Roles in mammalian development” 
Nat. Rev. Genet., vol. 14, no. 3, pp. 204–220, 2013.” 
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However, most of the DNA expanses are not compromised of genes and their 
regulatory areas, the largest expanses of genetic code in the human genome are comprised 
of regions of non-coding DNA that also undergo regulatory methylation. The 
pericentromeric repeats located at the chromosome’s centromere are crucial for correct 
chromosome alignment during mitosis. These areas contain two types of satellites: major 
satellites and minor satellites. DNMT3b acts on both methylation mechanisms alongside 
H3K9me3 Histone-lysine N-methyltransferase SUV39. The difference between both 
mechanisms lies in the necessity of the presence of LSH for methylation to occur in major 
satellites [25]. Long interspersed nuclear elements (LINE), short interspersed nuclear 
elements (SINE) and long terminal repeats (LTR) are vast sections of genetic code 
interspersed throughout the mammalian code and are kept under strict hypermethylation, 
with hypomethylation of some elements being linked to cancer [28]. The methylation of 
these areas of the genome are maintained by the same DNMT1 mechanism but  suffer  
hemimethylation and hydroxymethylation at a higher rate than the rest of the genome, 
requiring DNMT3a intervention more frequently [25]. 
The reaction consists in the addition of a methyl group to the 5’ carbon of the cytosine 
residues, creating 5'-methyl-cytosine, using S-Adenosyl methionine (SAM) as a donor (Fig. 
9). For the reaction to occur, a specific CpG motif called CpG site is required for recognition 
and binding to the correct location. Areas of the genome that contains a high frequency of 
these motifs are denominated CpG Islands. Although the CpG motif is required for DNMT 
activity and 60% to 90% of CpG sites being methylated [29], CpG Islands, sections of DNA 
that range from 300bp to 3000bp with a 55%+ CG content present in the 5’-end promoter 
regions are mostly unmethylated [30], and silencing of these areas is usually done by histone 
methylation (H3K27) [25]. High DNA methylation levels in this area renders downstream 
genes silenced and diminishes their expression considerably [31], leaving histone 
methylation as a failsafe against incorrect DNMT activity [25].  
If left unmaintained, and through influence of an organism’s ambient, age, health and 
many other external pressures, 5'-methyl-cytosine may suffer oxidation, turning into 5'-
hydroxymethyl-cytosine [30], which through DNA repair mechanisms suffers 
demethylation, either through deamination into a T:G mismatch with prompt repair to a C:G 
match or through deamination catalyzed by Activation-induced cytidine deaminase 
(AID)/Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) 
deaminase families into 5'-Hydroxymethyl-uracil which is excised and repaired by the Base 
excision repair (BER) pathway leaving an unmethylated cytosine in that position. 
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2.2. Genetics in Forensic Science  
 
Presently, the genetic field of science holds only one, yet key, practice in the forensic 
scope: the DNA profiling. DNA profiling is the process of identifying a series of extremely 
variable areas of the genetic code in a sample of genetic material in order to create an 
individual profile that can be used in matching procedures. Most of the human genetic code 
is shared amongst the entire population as is with only some small variable components, yet 
these areas within themselves can contain tremendous amounts of variability, known as 
polymorphic markers [32].  
Initially and currently, the main group of polymorphic markers used for DNA 
profiling is the STR, short tandem repeats. Short tandem repeats are repeats of 3, 4, 5 or 
Fig. 9- Possible mechanism of the DNA Methylation reaction between a cytosine 
nucleotide (center top), SAM (center bottom) and the catalytic center of DNMT (top right 
and top left). 
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more nucleotides present throughout the DNA that are repeated multiple times back-to-back 
several times. The differentiating factor between STR loci is the number of such repeats, 
with an individual being able to possess up to two different numbers of repeats for every 
STR loci, each chromosome having its own “allele”, inherited through the donating 
progenitor. STRs also work very alike genes when it comes to mutations and linkage. STR 
loci that are physically closer in a chromosome tend to stay together, as the chance of 
suffering separation through cross over is lower, meaning that variation in close loci is 
smaller than in loci far apart. In the same manner, STR can suffer mutations, albeit these 
may come not in the change of nucleotides, but at times in the number of overall repeats 
[33].  
The number of possible repeats in a certain locus itself is not a very large number, 
but the number of combinations when accessing an entire array of loci quickly becomes large 
enough for a particular combination of different alleles to be accepted as a fingerprint (Table 
1). 
 
Table 1- Frequently used STR loci in DNA profiling accepted by the various databases. 
Adapted from “E. Giardina, “DNA Fingerprinting” Brenner’s Encycl. Genet. Second Ed., 
vol. 2, pp. 356–359, 2013.” 
 
 
A battery of four and five nucleotide long repeats (tetranucleotide and 
pentanucleotide motifs, respectively)  STRs that are completely delinked and suffer low rates 
of mutations are  now used to create a DNA profile, with CODIS (Combined DNA Index 
System), the system used by the Federal Bureau of Investigation of the United States, using 
20 loci as a standard [34], the UK’s National DNA Database DNA-17’s system using 17 loci 
13 
 
[35], and the European Interpol operating on a cross-referencing overlapping system from 
several contributing countries with different numbers of required loci [36]. Alongside 
individual identification, STR based DNA profiles are also used for kinship tests due to the 
hereditary nature of STRs. Such tests are conducted using a battery of STRs similar to DNA 
profile batteries, ranging from 15 to 23 different loci [37], yet, unlike DNA profiles, operates 
solely on percentual chances calculated upon the presence or absence of similar alleles of 
the tested loci checked between the donor, known familiars if existent and individual whose 
kinship is in question. 
Outside of these individual identification and relation identification techniques that 
have been consolidated and accepted as viable evidence, all other applications of DNA,  
genetics and epigenetics in forensics are still in very early stages of study and development 
and/or need of applicability, such as the epigenetic determination of age and postmortem 
intervals in the first case and the use of epigenetic markers to distinguish the origins of DNA 
samples found in the crime scene, as coming from biological sources or created by laboratory 
procedures and planted in the local in the latter [30].  
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3. Model Organisms 
 
3.1. Zebrafish 
 
Zebrafish is a freshwater vertebrate from the Cyprinidae family hailing from the 
southeastern Himalayan region [38] with populations near Asiatic regions such as Pakistan, 
Bangladesh, India and Nepal [39]. The species was named by Francis Buchanan-Hamilton 
[40], a Scottish physician that spent many years studying the flora and in the southern India.  
Zebrafish is a small fusiform fish with 5 longitudinal blue stripes that run from its 
branchial arch until the end of the caudal fin, with extra stripes running parallel on the pelvic 
fins. The color of the complementary stripes is different from males to females, prior ones 
having golden stripes and later ones possessing white to silvery stripes (Fig. 10). Individuals 
can grow up to 6 centimeters with a mean size of 4 centimeters in laboratory conditions [41]  
and can survive up to 5 years with the average lifespan being roughly three and a half years. 
 
It’s an organism with rising popularity as a model organism over the years to be used 
for a wide array of genetic studies. Albeit being further taxonomically from humans than 
mice, Zebrafish share many orthologue genes with humans, with 71.4% of human genes 
having at least one zebrafish orthologue, and of those, 47% have a one-to-one relationship 
with a zebrafish orthologue [42].  
Zebrafish also provide some benefits over mice as model organisms through the 
sheer number of individuals that can be bred, matured, monitored and used for testing in a 
smaller time frame and laboratorial installations, allowing for far more iterations of the 
procedure for a much lower cost, providing an opportunity to amass much more data for data 
Fig. 10- A male zebrafish (top, golden stripped) and a female zebrafish (bottom, 
silver stripped). Adapted from http://www.brainn.org.br/zebrafish-um-peixe-com-
vocacao-para-pesquisas-geneticas/. 
15 
 
driven studies while not sacrificing any quality or relevance. This is particularly useful when 
trying to amass sufficient data to create any sort of standard or even proof of concept. 
In terms of DNA methylation, zebrafish possess a relatively simpler overall system 
for their epigenetic code, not needing genetic imprinting nor sex chromosome imprinting to 
produce viable individuals [43]. Despite that, the zebrafish’s methylation machinery shares 
many important orthologs with mammalians, most importantly being DNMT1, DNMT2 and 
DNMT3 orthologues [43]. Zebrafish’s DNMT1 and human’s DNMT1 share a 73% 
similarity overall, with a 89% identity in the catalytic domain [43], as well as an uhrf1 
orthologue with 66% similarity [44]. Ubiquitin like with PHD and ring finger domains 1 
(uhrf1) is a necessary protein for correct embryo development and tissue proliferation [44] 
as it binds to hemi-methylated DNA, recruiting DNMT1. Zebrafish’s DNMT4 also possesses 
a 68% amino acid sequence identity with human DNMT3b, the protein responsible for many 
de novo methylations [43]. Human DNMT3a is also represented in the zebrafish’s machinery 
by the orthologues DNMT6 and DNMT8, with an overall 77% identity and 89% catalytic 
domain [43]. The presence of these proteins ensures that zebrafish have de-novo and 
maintenance methylation akin to mammals, making them an appropriate organism to base 
early methylation related studies on. 
 
Fig. 11- Structure of the eight DNMT orthologues present in zebrafish. There is bromo-
adjacent homology domain (BAH) on DNMT1, calponin homology (CH) on DNMT3 and 
DNMT7, cysteine-rich domain (CXXC) on DNMT1, conserved proline-tryptophan-trypto-
phan-proline domain (PWWP) throughout DNMT3 to DNMT8, and ATRX-DNMT3-
DNMT3L domain (ADD) throughout DNMT3 to DNMT8. Adapted from “N. Shimoda, K. 
Yamakoshi, A. Miyake, and H. Takeda, “Identification of a gene required for de novo DNA 
methylation of the zebrafish no tail gene” Dev. Dyn., vol. 233, no. 4, pp. 1509–1516, 
2005.” [38] 
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3.2. Laboratory Mouse 
 
Mus Musculus is one of the most widespread model organisms to date, being only 
rivaled by Drosophila Melanogaster. The laboratory mouse is a small furry rodent, with an 
average of 8.75 cm from snout to tail and an average tail length of 7.5 cm with a fur coat 
ranging from black to brown to white with a life expectancy of two to three years in average, 
with different strains affecting the range. 
  
Fig. 12- A C57BL/6 mouse (left) and a BALB/c mouse (right). Adapted from 
https://www.jax.org/ 
 
The species began being inbred for scientific purposes in 1907 by Clarence Cook 
Little [45], with two years afterwards being obtained two mice with the recessive genes three 
of the characteristics in study. Descendants of these two mice where then bred over multiple 
generations, creating the first strain, dba [45]. From that strain, many more were created 
alongside others that were bred from wild type progeny (Fig. 13). 
 
Fig. 13- Laboratory mouse strains tree from 1909 to 1960. Adapted from “Roscoe B. 
Jackson Memorial Laboratory, Biology of the laboratory mouse, 2nd ed. New York: 
Dover Publications, Inc, 1966.” 
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 From then on, many more strains were developed by many laboratories, many 
specifically created, either for just certain studies or for valued traits, with as of 2017 the 
total mice references and citations used totaling over 69000, with inbred strains being the 
most used at over 23000 references, in the PUBMED database [46]. From these numbers, 
the two most used and referenced strains where the C57BL/6 and the BALB/c strains (  
Fig. 12). The strain C57BL/6 was the first one to have its entire genome sequenced, 
in 2012 and it continues being the preferred strain due to this fact and also because it’s a 
generally stable strain that’s also easy to breed, also being affected by less pathologies that 
its peers [46]. 
The laboratory mouse shares a more similar methylation mechanism to humans than 
the zebrafish, with the DNMT1 orthologues sharing a 76% protein identity, DNMT3a 
orthologues a 92% protein identity, DNMT3b orthologues a 76% protein identity and 
DNMT3L orthologues a 57% protein identity. These proteins share the same function as in 
humans, DNMT1 maintaining DNA methylation, DNMT3a and DNMT3b being responsible 
for de novo methylation, with the regulatory function of DNMT3L. Mice do possess a third 
de novo DNMT, named DNMT3c, evolved through DNMT3b duplication, responsible for 
the methylation of promoters of recent retrotransposons in the male germ line, being 
necessary for male fertility [47]. 
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4. Candidate Biomarkers 
 
4.1. Global DNA Methylation 
 
Global DNA methylation is the first biomarker that should be taken into 
consideration in the context of a forensic epigenetic analysis as it can function both as a 
preliminary viability check for the sample and as an internal reference to contextualize all 
further data obtained. Global DNA methylation decays naturally, both in vivo and 
postmortem, at yet unknown rates postmortem. These rates are key to the overall process of 
determining the PMI of a body using epigenetics. This is due to two facts: either the 
technique requires input DNA normalization which renders the global DNA methylation as 
the only way to normalize the epigenetic information of a given sample to the standard ladder 
or the technique can accept various ranges of input DNA, which can severely boost or 
diminish overall DNA methylation values in specific biomarkers.  
 
4.2. Housekeeping genes 
 
One of the characteristics that is highly valued in a forensic science is its stability 
against adverse conditions, yet for the purpose of PMI estimation, stability of the methylation 
status throughout the organism’s life would be key. Genes that keep their methylation stable 
as an organism ages, changes and suffers environmental stresses would provide a biomarker 
with less variance than other genes. Candidates for these kinds of genes would be 
housekeeping genes, genes that are absolutely necessary for the most basic functions of a 
cell, being expressed at basal levels in all cells of all tissues at all stages of development, 
even though the vast, vast majority of pathologies [48], albeit the amount of expression basal 
is might differ from author to author. Eisenberg et al. definition of housekeeping genes is to 
have a geometrical mean expression over 50 Reads Per Kilobase Million in RNA-seq and 
no tissue having expression deviation from the geometrical mean by a factor of two or 
superior (Table 2). As their expression is required, these genes may be in a permanent state 
of relative hypomethylation to no methylation, requiring a more sensitive technique for their 
study in the first case or be completely disregarded in the latter, or be used as a negative 
internal control for the standard. 
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Table 2- List of housekeeping genes. Data partially adapted from “E. Eisenberg and E. Y. 
Levanon, “Human housekeeping genes, revisited” Trends Genet., vol. 29, no. 10, pp. 569–
574, 2013.”, “J. Pampel, “Housekeeping genes” 2017. [Online]. Available: 
https://www.genomics-online.com/resources/16/5049/housekeeping-genes/. [Accessed: 04-
Sep-2019]” [49] and “C. Zhang, Y. Q. Wang, G. Jin, S. Wu, J. Cui, and R. F. Wang, 
“Selection of reference genes for gene expression studies in human bladder cancer using 
SYBR-green quantitative polymerase chain reaction” Oncol. Lett., vol. 14, no. 5, pp. 6001–
6011, 2017.” [50] 
 
 
 
Symbol Name Function 
Eisenberg et al.’s list of reference genes 
C1orf43 
Chromosome 1 open 
reading frame 43 
 
CHMP2A 
Charged multivesicular 
body protein 2A 
Core component of the transport complex III 
(ESCRT III), which is involved in all ESCRT 
machinery mediated processes [51]. 
EMC7 
ER membrane protein 
complex subunit 7 
 
GPI 
Glucose-6-phosphate 
isomerase 
Interconverts glucose-6-phosphate and 
fructose-6-phosphate. Core cellular 
respiration enzyme. 
PSMB2 
Proteasome subunit beta 
type 2 
Component of the 20S core proteasome 
complex involved in the proteolytic 
degradation of most intracellular proteins 
[52]. 
PSMB4 
Proteasome subunit beta 
type 4 
Component of the 20S core proteasome 
complex involved in the proteolytic 
degradation of most intracellular proteins 
[53]. 
RAB7A 
Member RAS oncogene 
family 
Involved in all stages of endosomal 
maturation, all microtubule directed 
endosomal migration and positioning, 
endosome-lysosome transport, core protein in 
growth factor mediated cell signaling, 
nutrient-transporter mediated nutrient uptake, 
neurotrophin transport in the axons of neurons 
and lipid metabolism [54]. 
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REEP5 
Receptor accessory 
protein 5 
 
SNRPD3 
Small nuclear 
ribonucleoprotein D3 
Core component of the spliceosome, a nuclear 
ribonucleoprotein complex that catalyzes 
RNA splicing [55].  
VCP 
Valosin containing 
protein 
Part of the AAA ATPase family of proteins. 
Performs necessary functions in protein 
degradation, intracellular membrane fusion, 
DNA repair and replication, regulation of the 
cell cycle, and activation of the NF-kappa B 
pathway [56]. 
VPS29 
Vacuolar protein sorting 
29 homolog 
Component of the retromer cargo-selective 
complex, core functional component of 
retromer or respective retromer complex 
variants that prevents missorting of 
transmembrane cargo proteins into the 
lysosomal degradation pathway [57]. 
Other reference genes / housekeeping genes 
RRN18S 18S ribosomal RNA 
18S rRNA is a component of the 40S small 
eukaryotic ribosomal subunit, constituting the 
structural RNA for the small component of 
eukaryotic cytoplasmic ribosomes. Proposed 
to be used as a reference gene in renal cell 
carcinoma [58]. 
RPS23 
40S ribosomal protein 
S23 
A protein that is a component of the 40S 
eukaryotic ribosomal subunit.  
RPS13 
40S ribosomal protein 
S13 
A protein that is a component of the 40S 
eukaryotic ribosomal subunit.  
ATP5B 
β- ATP Synthase F1 
Subunit 
Beta subunit of the catalytic core of the 
mitochondrial membrane ATP synthase [59]. 
HSP90AB1 
Heat Shock Protein 
90kDa Alpha (Cytosolic), 
Class B Member 
Molecular chaperone involved in maturation, 
structural maintenance and regulation of 
specific target proteins involved in cell cycle 
control and signal transduction [60]. 
S100A6 
S100 Calcium Binding 
Protein A6 
Acts as calcium sensor and modulator in 
cellular calcium signaling [61]. 
UBB β-Ubiquitin  
Ubiquitin is a highly conserved protein that 
has a major role in 26S proteasome mediated 
cellular proteins degradation. It has other 
roles in the maintenance of chromatin 
structure, regulation of gene expression and 
stress response [62]. 
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POLR2A 
RNA Polymerase II 
Subunit A 
It’s both the largest and catalytic component 
of RNA polymerase II, responsible for 
synthesizing mRNA precursors functional 
non-coding RNAs [63]. 
ACTB β-Actin  
Major component of the contractile apparatus 
and one of the two non-muscle cytoskeletal 
actins [64].  
GAPDH 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
Catalyzes the reversible oxidative 
phosphorylation of glyceraldehyde-3-
phosphate in the presence of inorganic 
phosphate and nicotinamide adenine 
dinucleotide (NAD). Core cellular respiration 
enzyme [65]. Proposed to be used as a 
reference gene in renal cell carcinoma [58]. 
PGK1 
Phosphoglycerate kinase 
1 
Catalyzes the conversion of 1,3-
diphosphoglycerate to 3-phosphoglycerate. 
Core cellular respiration enzyme [66]. 
PPIA 
Peptidylprolyl isomerase 
A 
Speeds up protein folding [67]. 
RPL13A Ribosomal protein L13a 
A protein that is a component of the 60S 
eukaryotic ribosomal subunit. Has a minor 
role in the repression of inflammatory genes 
as a component of the IFN-gamma-activated 
inhibitor of translation (GAIT) complex [68]. 
RPLP0 
Ribosomal protein, 
large, P0 
A protein that is a component of the 60S 
eukaryotic ribosomal subunit [69]. 
B2M β-2-microglobulin 
Component of the class I major 
histocompatibility complex involved in the 
presentation of peptide antigens to the 
immune system [70]. 
YWHAZ 
Tyrosine 
3-monooxygenase / 
tryptophan5-
monooxygenase 
activation protein, zeta 
polypeptide 
Highly conserved protein that mediates signal 
transduction by binding to phosphoserine-
containing proteins [71]. 
Proposed to be used as a reference gene in 
renal cell carcinoma [58]. 
SDHA 
Succinate dehydrogenase 
complex, subunit A, 
flavoprotein 
Core catalytic subunit of succinate-
ubiquinone oxidoreductase, part of a core 
cellular respiration enzyme [72]. 
TFRC Transferrin receptor 
Protein responsible for cellular iron intake 
through the receptor-mediated endocytosis of 
ligand-occupied transferrin receptor into 
specialized endosomes [73]. 
GUSB β-Glucuronidase 
Hydrolase that catalyzes the anabolism of 
glycosaminoglycans [74]. 
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HMBS 
Hydroxymethylbilane 
synthase 
Third enzyme of the heme biosynthetic 
pathway catalyzing the head-to-tail 
condensation of four porphobilinogen 
molecules into the linear 
hydroxymethylbilane [75]. 
HPRT1 
Hypoxanthine 
phosphoribosyltransferase 
1 
Catalyzes the conversion of guanine into 
guanosine monophosphate and hypoxanthine 
into inosine monophosphate, being a core 
enzyme of the purine salvage pathway [76]. 
TBP 
TATA box binding 
protein 
General transcription factor that is at the 
central enabling role in the DNA-binding 
multiprotein factor TFIID’s function [77]. 
  
4.3. LINE-1 and repetitive DNA 
 
LINEs, or long interspersed nuclear elements, are a form of repetitive DNA that 
constitutes roughly 21% of the human genetic code, that in conjunction with other form of 
repetitive DNA constitute half of entirety of the human genome [78]. These repetitive DNA 
section can be categorized firstly in two ways: sections that repeat themselves in succession, 
back to back, are denominated satellites and sections that repeat themselves throughout the 
entire genome in small patches are denominated interspersed repeats, that are derived from 
retrotransposons. These interspersed repeats can be subdivided even further by the presence 
or absence of a long terminal repeat (LTR), defining LTR retrotransposons and non-LTR 
retrotransposons. LINE-1s are the denomination of the latter, retrotransposon based mobile 
interspersed repeats without long terminal repeats of up to 6kb in length, with nearly 500000 
copies in the human genome, 3000 to 4000 copies present in a non-truncated form and 30 to 
100 copies being in their active retrotransposon form, constituting in total 17% of the human 
genome [78]. They are hypermethylated in normal cells, with constant maintenance of the 
methylation status through the pattern keeping mechanisms from DNMT1, but suffer   
accelerated demethylation, requiring the recruitment of TET and DNMT3a to remake the 
methylation pattern de novo [25]. As a consequence of the large portion of the genome that 
LINE-1s comprise alongside their rigorous hypermethylation status, LINE-1 methylation, 
alongside other similar repetitive elements like Alu, a non-LTR short interspersed nucleotide 
element (SINE) that comprises roughly 10% of the human genome, can be used as a partial 
substitute for, or accompaniment to, global methylation levels  [28], [79]. 
 Another form of repetitive DNA present well disseminated throughout the human 
genomes is the large tandemly repeated, generally short-sequenced, non-coding satellite 
DNA. These large areas of repetitive DNA are present mostly in the centromeres of the 
chromosomes and some are present in the heterochromatin [80]. In the human genome there 
are several note-worthy satellites: Satellite α, Satellite β, Satellite 1, Satellite 2 and Satellite 
3. The most ubiquitous of them, Satellite α, is present in the centromeres of all of the 
chromosomes, with repeating patterns of 171bp monomers, with the number of different 
monomers tandemly repeating in a certain order being called the higher order repeat, 
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identifying the chromosome it belongs to [81]. As such, every chromosome has a different 
sequence for its Satellite α, but as the area spans over several mega bases of highly identical 
arrays, making up to 3% of the total human genome [82], it becomes hard to sequence using 
short sequence reads, appearing homogenous in such cases [81]. These areas of the genome 
do undergo DNA methylation and regulation, and, albeit direct causation is still under debate 
and study, methylation instability in the form of hypomethylation of the satellite DNA 
appears correlated with chromosome instability, breakage and creation of micronuclei, with 
normal levels of methylation being inhibitors of recombination between the highly similar 
repetitive areas of the pairing chromosomes [82]. On oncology based studies, 
hypomethylation of satellite DNA was linked to the genomic instability that is common 
occurrence in, or may even cause, the pathology [83]. Therefore, these areas undergo strict 
methylation regulation, and so, they are prime candidate target biomarkers that, unlike 
LINE-1s, are not wide-spread enough to be used as a global methylation surrogate but rather 
biomarkers tested for variability in the battery. 
 
4.4. Individual target biomarkers 
 
As for possible individual genes that suffer a sustained, stable rate of degradation of 
their methylation pattern in postmortem bodies exposed to natural elements, not much 
information has been gathered by the general scientific community. In regards to the creation 
of a PMI assessing battery, the exhaustive study and search for potential individual target 
biomarker candidates will constitute most of the work needed to be done in order to create 
the biomarker battery after the pilot, proof-of-concept, forensic focused studies have firmly 
demonstrated that such methodology is viable. Most of the information that can be foraged 
from the current epigenetic studies pertain to premortem changes in many genes, be it 
susceptibility to environmental pressures, linkage to passage of time premortem, and other 
factors, denoting individual genes that may possess initial methylation patterns at time of 
death too variable to provide reliable results in a standard. Tentative lists of genes that fall 
under this category are located under Chapter 6.3, Obstacles to Overcome, and Table 2. 
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5. Laboratorial Techniques 
 
5.1. The Scope  
 
The sheer number of techniques that were created with the sole purpose of, or that 
can be used to, study DNA Methylation is extensive (Fig. 14). They can be divided into three 
main groups: bisulfite conversion-based techniques; techniques that leverage affinity to 
methylation antibodies; restriction enzyme-based techniques. There is also a smaller group 
of broader quantitative and qualitative techniques that are used for other areas of expertise 
that can be used to measure methylation through small clever protocol tweaks. These three 
main groups contain a plethora of different options, far too many for the scope of this work, 
so a selection of procedures from each group fitting to the end goal of using epigenetics to 
determine PMI shall be explored.  
 
 
Fig. 14- A comprehensive list of the most used DNA methylation assessing techniques. 
Adapted from “E. Olkhov-Mitsel and B. Bapat, “Strategies for discovery and validation of 
methylated and hydroxymethylated DNA biomarkers” Cancer Med., vol. 1, no. 2, pp. 237–
260, 2012.” [84]. 
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5.2. Bisulfite Conversion 
 
Sodium bisulfite conversion consists on the mutation of unmethylated cytosine 
residues into uracil residues, and subsequent conversion to thymine if converted to cDNA, 
effectively translating epigenetic information into genetic information, making it an 
absolutely cornerstone technique for many epigenetic studies. Initially, bisulfite causes the 
sulphonation of an unmethylated cytosine on the 6’ carbon, adding a -SO3 group, turning it 
into a cytosinsulphonate. With a following hydrolytic deamination, cytosinsulphonate is 
converted into uracilsulphonate, an uracil residue with a -SO3 group on his 6’ carbon. 
Finally, a desulphonation returns uracilsulphonate to a normal uracil residue, thus 
completing the conversion [85] (Fig. 15). The resulting DNA will reveal the presence of 
methylation in a certain cytosine residue if when matched with unconverted DNA no change 
has been caused and will reveal the lack of methylation when an uracil, or thymine if 
processed, is present in a cytosine location.  
 
 
 
 
 
 
 Many of the methylation accessing techniques require prior bisulfite conversion to 
enable them to obtain the pretended results. Methylation-Specific PCR, HRM Analysis, 
COBRA Methylation Assay and Bisulfite Pyrosequencing require the bisulfite conversion 
[86], [87]. Common usage bisulfite conversion kits from Qiagen, Analytik Jena and Zymo 
Research were tested by efficiency, with results ranging from 98.7% to 99.9% [88]. Despite 
high conversion rates, bisulfite conversion protocols are carried under very unfavorable 
conditions for DNA stability, resulting in longer conversion protocols having higher rates of 
DNA fragmentation  [88]. 
 
5.3. PCR, qPCR and Methylation-Specific PCR (MSP) 
 
Polymerase Chain Reaction (PCR) was one of the biggest breakthroughs in recent 
story for many fields of science. In the last 36 years, from biology to forensic sciences, since 
the technique was created and refined by Kary Mullis in 1983, the ability to amplify a sample 
of DNA quickly and efficiently has grown to a day-to-day basic necessity for many 
laboratories [89].  
The technique consists on a simplified in-vitro recreation of the DNA replication that 
occurs on living organisms. It occurs in 3 main phases: 
• Denaturation: A small portion of the DNA sample or complementary DNA 
created out of an originally RNA sample is heated enough to melt its double 
helix structure and create single stranded DNA. 
Fig. 15: Depiction of the four stages of a Bisulfite conversion of cytosine. 
26 
 
• Annealing: The temperature is lowered just enough to allow the primers to 
bind to the DNA around the area of interest to elongate. The design of the 
primers is critical both to achieve total annealing of the primers at a 
temperature that does not allow for non-specific annealing between single 
stranded DNA and to achieve amplification of the specific genetic material 
of interest in the case of qualitative PCR. 
• Extension: The temperature is adjusted towards the optimal catalytic 
conditions for the DNA polymerase in use, usually Taq DNA Polymerase, 
which will elongate the DNA chain from the primers using the single strand 
DNA as a base. By the end of this phase, the total amount of DNA present 
will have theoretically doubled. [90] 
The reaction is run for several cycles which fall into three categories differentiated by the 
amount of new copies generated per cycle: 
• Initiation phase: In this phase, each cycle produces small amounts of new 
copies as there are few copies to copy from. 
• Exponential phase: In this phase, each cycle produces larger and larger 
amounts of copies. 
• Plateau phase: In this phase, each cycle slows down the amounts of copies 
made due to the rising scarcity of nucleotides to fuel the DNA Polymerase, 
until copies cease to be created and the reaction ends. 
While PCR may be a simple process nearly completely automated in current days, 
many tweaks have been done to the core protocol in order to use the technique as a method 
of obtaining data by itself, and not merely be used to obtain enough sample for posterior 
analysis. Real time PCR (qPCR) is one of these variants of the PCR technique capable of 
providing data about the quantity of replicated DNA present in each cycle in real time. 
Through the addition of fluorescent dyes like SYBR Green I that only fully activates when 
intercalated with double-stranded DNA, qPCR allows the total quantification of replicated 
sequences plotted against time. If short sequence-specific DNA or RNA sequences labelled 
with a fluorescent reporter and a quencher that is active until hybridization, known as 
hybridization probes, are instead added, qPCR allows for the quantification of the replication 
of precise DNA sequences in a sample containing several sequences plotted against time. 
Methylation-specific PCR (MSP) is another tweak to the PCR protocol, taking basis 
on the regular qPCR technique, tailored to be sensitive towards methylation patterns within 
the DNA sample provided. This sensitivity is achieved through the usage of primers 
designed to be complementary to the sequence in the targeted area of interest post bisulfite 
conversion [22]. Since methylated cytosines are protected from the mutation induced by the 
bisulfite conversion, epigenetic information is transformed into sequence information that 
can be targeted with primers that will only anneal to the sample DNA if it had previously a 
certain methylation pattern. As such, methylation data is read through difference in Ct 
values. The downside of this technique is that the methylation locations accessed by it is 
limited by the numbers of primers available, and each addition of methylation location 
testing primer incurs higher costs. 
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5.4. HRM Analysis 
 
The HRM analysis consists on the comparison between the melting temperature of a 
double strand of DNA to another, in order to either spot differences like point mutations 
between very similar sequences or group several sequences according to the variable in 
study, with DNA methylation being the one in focus on this work [91].  
A typical HRM analysis starts with a PCR in order to amplify the samples of interest to 
be compared. Then, with the addition of intercalating fluorescent dyes to allow the process 
to be monitored in real time like qPCR and a slow and steady warming of the samples, the 
melting of the DNA is registered for each sample in the form of a graph depicting 
fluorescence against temperature, in a downward fashion, when normalized, due to the fact 
as more DNA denatures, more of the intercalating dyes are released and overall fluorescence 
diminishes. Then, the samples are compared based on the overall graphic and melting 
temperature, the temperature at which 50% of the double strands have melted. This is 
possible because the two different base pairs have different proprieties. The G-C base pairing 
is held by 3 hydrogen bonds while the A-T base pairing is held by 2, making a G-C base 
pairing heavy sequence more resistant to melting than a A-T heavy one [18]. Even single 
point mutations replacing one pairing with another can create a significant enough difference 
between the melting temperatures to be detectable and registered. 
Paired with MSP, an HRM analysis can be done in the same protocol in order to further 
validate the obtained results. If a standard is created using DNA methylation for post mortem 
analysis, a quick HRM analysis can be used to group the standard ladder and place the 
sample within one of those groups, either authenticating the MSP results by grouping with 
the same range of PMI or denoting an error in the process.  
 
5.5. ELISA Assay Technique 
 
The ELISA assay technique, or enzyme-linked immunosorbent assay, is a plate-
based assay technique that can be used to quantify a myriad of molecules ranging from 
peptides to macromolecules. 
Albeit several types of ELISAs exist, every type has its foundation on the binding of 
antibodies to the antigen to quantify the intended molecule, depending merely on how direct 
the measurement is done. In direct capture ELISAs, the complex reactional mixture where 
the antigen to quantify resides is simply placed within the well, where the antigen is bound 
to. In indirect capture ELISAs, well-bound antibodies are selective to the antigen to quantify, 
binding it to the well [92].  
Disregarding the capture type, the detection of the antigen to quantify can also be 
separated into two types. In direct detection, the wells are flooded with selective antibodies 
conjugated with a reporter which will bind to the antigens in a one-on-one fashion. In indirect 
detection, also known as Sandwich ELISA, firstly the wells are flooded with unconjugated 
antibodies that will bind to the antigen. Afterwards, the wells are flooded with antibodies 
conjugated with reporters that will bind to the first antibodies, with one of these first ones 
28 
 
being able to bind more than one conjugated antibody [92]. Finally, in both detection types, 
the wells are washed and then substrate is added to activate the reporters and allow 
quantification. As indirect detection allows more reporters per antigen, it suffers signal 
amplification, augmenting the technique’s sensitivity, being currently the most robust option 
[92].  
 
Fig. 16- Illustration of the two types of ELISA detection, direct and indirect detection, on a 
direct capture protocol (left and middle) and the sandwich Elisa diagram (right). Adapted 
from: “ThermoFisher, “Overview of ELISA.” [Online]. Available: 
https://www.thermofisher.com/pt/en/home/life-science/protein-biology/protein-biology-
learning-center/protein-biology-resource-library/pierce-protein-methods/overview-
elisa.html. [Accessed: 18-Jul-2019]”. 
 
Antigens can be designed to bind to methyl groups, so when DNA samples are tested 
through ELISA based assays, methylation information is read and amplified directly from 
the source, although no gene specificity can be achieved without previous DNA cutting and 
only inserting the wanted genes into the reaction wells, adding more steps to the protocol 
that can damage the source material. Even so, ELISA based assays are a prime candidate for 
global methylation assessment, with relative ease and low cost.  
 
5.6. Methylated DNA immuno-precipitation (MeDIP) 
 
Methylated DNA immuno-precipitation is a laboratorial technique based on 
immunocapturing that allows for the enrichment of methylated DNA [93], [94]. The protocol 
consists on the cleavage of DNA either by restriction enzymes or sonication to the desired 
fragment length, followed by the separation into two samples, input DNA that is left as is 
and immunoprecipitated DNA that will undergo the rest of the protocol. The 
immunoprecipitated DNA then undergoes denaturation and immunoprecipitation by Anti-5-
methylcytosine (5-mC) antibodies and is purified (Fig. 17) [93], [94]. The protocol itself 
does not produce any data results, instead it produces two different samples from the original 
one that can be put through PCR, qPCR and oligonucleotide microarray protocols for the 
data to be accessible [94].   
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Fig. 17- The schematic of a MeDIP methylated DNA enrichment protocol. Adapted from 
“F. Mohn, M. Weber, D. Schübeler, and T.-C. Roloff, “Methylated DNA 
Immunoprecipitation (MeDIP)” 2008.” 
  
The data from qPCR and oligonucleotide microarrays are the most reliable for 
forensic usage, and covers the entire genome, with the latter one possessing an 80kb 
resolution [93]. In qPCR, the more methylated the original sample is, the closer the Ct value 
for the IP DNA will be in comparison to the Input DNA’s Ct value. Paired with HRM 
analysis, this sequence of protocols could be a strong candidate for a fast, cheap and reliable 
protocol for PMI assessment, as DNA degradation and denaturation’s effects on the initial 
steps of the protocol may be minimal.  
 
5.7. Bisulfite Pyrosequencing 
 
Bisulfite Pyrosequencing is a technique that allows the study of the methylation state 
of singular CpG locations at a quantitative level. It starts with a bisulfite conversion of the 
DNA sample, followed by a variation on the PCR protocol, modifying the primer 
complementary to the CpG location of interest, by adding biotin to the 5’-end of the primer. 
After PCR amplification, the biotin bound primer becomes the template for the 
pyrosequencing, that is isolated through denaturation of the double-stranded amplicon and 
filtration through streptavidin beads [95]. The high affinity between biotin and streptavidin 
separates the sample DNA and the amplified template primer. Then the technique follows a 
standard pyrosequencing protocol. The amplified template primer is incubated alongside: 
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DNA polymerase, present to allow the incorporation of dNTPs;  ATP sulfurylase, that will 
catalyze the conversion of the pyrophosphate produced by the incorporation of dNTPs into 
ATP;  luciferase, that will use the ATP as fuel to convert luciferin into oxyluciferin; apyrase, 
present to digest the remaining non-incorporated dNTPs; substrates needed for the enzymes, 
such as adenosine 5' phosphosulfate for ATP sulfurylase and luciferin for luciferase [87], 
[95]. After incubation, a solution of a single kind of dNTP is added to the reaction. DNA 
polymerase will try to incorporate them into the growing complementary strand and, if 
successful, release pyrophosphate that will trigger the cascading reaction and result in 
measurable light emission (Fig. 18). Since the light emitted is proportional to the amount of 
incorporated dNMT, the presence of light at the time of addition of a thymine will denounce 
a methylated cytosine in the original sample and presence of light at the time of cytosine 
addition will denounce an unmethylated cytosine. This is so because the template used for 
the pyrosequencing is a complementary strand to the original sample, possessing an 
adenosine on the CpG location in study for the first case and a guanine for the latter. 
 
 
Fig. 18- The resulting pyrophosphate from the dNTP incorporation will allow the ATP 
sulfurylase to catalyze ATP, which is used by luciferase to catalyze luciferin into 
oxyluciferin, producing light. Apyrase present in the reaction will digest any unused 
dNTPs and ATP, resetting the reaction for the next addition of dNTP. Adapted from: 
“QIAGEN, “Pyrosequencing Technology and Platform Overview” 2019. [Online]. 
Available: https://www.qiagen.com/us/service-and-support/learning-hub/technologies-
and-research-topics/pyrosequencing-resource-center/technology-overview/. [Accessed: 
16-Jul-2019].”  
 
 The usage of single CpG Island methylation for forensic usage has not been studied, 
both in terms of identification and postmortem interval calculation most likely because its 
focus on small possible changes could be used more akin to SNPs in order to create a profile 
and not for bulk degradation analysis, but suffering the lack of enough polymorphism that 
SNPs provide and possible connection to lifestyle and health, making such small variances 
very unreliable. A comprehensive gene methylation assessment would provide a much more 
reliable source on information to be used. 
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5.8. HELP Methylation Assay 
 
The HpaII tiny fragment Enrichment by Ligation-mediated PCR (HELP) assay 
technique cleaves the DNA using the HpaII restriction enzyme and the isoschizomer Msp1 
restriction enzyme [96]. HpaII is an enzyme that cleaves unmethylated 5’ – CCGG – 3’ 
locations, while Msp1 cleaves any 5’ – CCGG – 3’ location regardless of methylation status. 
This creates two sets of cleaved DNAs 
differentiated by the methylation status. 
HpaII will not cleave methylated 
locations that Msp1 does, creating 
different length strands that will be used 
in the following ligation-mediated PCR 
as samples. It is necessary to note that for 
each cleavage site on any biomarker in 
stud, that total minus one different sets of 
primers must be designed that 
individually label each cleaved strand 
sample [97]. 
Before resuming the standard 
PCR protocol, each cleaved strand 
sample must be converted into an 
amplifiable, labeled product. Firstly, the 
cleaved DNA is denatured, and the first 
primer is extended along the cleaved 
strand sample. Then the sample is 5’-end 
capped using a DNA ligase to add a 
linker. Now the capped sample can be 
used in a PCR using the second primer 
and a linker primer to exponentially 
duplicate the sample strand. Finally, on 
the last cycle, a labeled third primer is 
used for data analysis purposes (Fig. 19) 
[98]. 
This technique falls more on the 
qualitative analysis side than the 
quantitative side [97] and does not 
possess CpG island bias [99], although 
only 3.9% of all non-repeat CpG 
locations in the human genome fall under HpaII’s recognized motif, severely limiting 
possible biomarkers [94]. Another hurdle for the usage of HELP for forensic protocols is 
that the original sample DNA must be intact [97]. DNA degradation may cause methylation-
Fig. 19- Illustration of the protocol sequence of a 
HELP assay. Adapted from “P. R. 
Mueller, B. Wold, and P. A. Garrity, 
“Ligation-Mediated PCR for Genomic 
Sequencing and Footprinting” in Current 
Protocols in Molecular Biology, 2004.” 
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unrelated cleavage points that skew the results, highly decreasing fidelity on longer PMIs, 
possibly making it unsuitable for forensic standards.    
 
5.9. Luminometric Methylation Assay (LUMA) 
 
The Luminometric Methylation Assay is another technique that is based on using the 
HpaII restriction enzyme and the isoschizomer Msp1 restriction enzyme, with the addition 
of EcoRI, a restriction enzyme that cleaves 5’ – AATT – 3’, as internal reference, followed 
by a pyrosequencing protocol [100]. The cleavage points of HpaII and Msp1 leave a 5’ – 
CG – 3’ overhang and the EcoRI cleavage points leaves an AATT overhang that are used in 
the pyrosequencing technique to obtain the results. In the first step of the pyrosequencing, 
dATPαS is added, filling the 5’ – TT – 3’ overhang on the extension process, giving out the 
first control signal. The second step consists in adding dCTP and dGTP to the sequence, 
filling all 5’ – CG – 3’ overhangs left by both HpaII and Msp1, giving out the sample results. 
Steps three and four are the addition of dTTP and another round of dCTP and dGTP. The 
first will finish filling the EcoRI overhang and provide the second and final internal reference 
results, while the second one is expected to not produce any signal, as all 5’ – CG – 3’ 
overhangs should be completely filled, serving as a protocol integrity check (Fig. 20)[100]. 
 
Fig. 20- Simplified visualization of a LUMA protocol. All data is retrieved in the form of a 
pyrogram (top right). Adapted from “M. Karimi et al., “LUMA (LUminometric 
Methylation Assay)-A high throughput method to the analysis of genomic DNA 
methylation” Exp. Cell Res., 2006.” 
 
Each sample is subjected to a HpaII/EcoRI and a Msp1/EcoRI treatment separately, 
with the results being given as a ratio between (HpaII/EcoRI) / (Msp1/EcoRI), becoming 
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HpaII/Msp1. This internal reference eliminates result variations depending on the amount of 
input DNA [100]. Another benefit of this technique above HELP assays is that the 
HpaII/EcoRI coefficient can be used in isolation, as it mirrors the HpaII/Msp1 coefficient, if 
the amount of available sample DNA is small, slashing the required amount in half (Fig. 21).  
The LUMA assay is a prime candidate for a global methylation test on the entire 
genome for its high scalability and simple protocol, being a much more promising technique 
in the forensic areas than bisulfite 
pyrosequencing and HELP assays. The hurdle it 
may face when used in forensic sciences is that 
extensive DNA degradation might skew the 
results in the same way as in the HELP assay. 
 
5.10. COBRA Methylation Assay 
 
COBRA methylation assays are yet another restriction-based protocol to determine 
methylation status. COBRA protocols start with a standard bisulfite conversion, followed by 
PCR amplification using methylation independent primers. After purification, BstUI 
restriction is applied. Finally, through polyacrylamide gel electrophoresis, the data is 
analyzed (Fig. 22) [101].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21- LUMA DNA methylation analysis of four 
HCT116 cell lines, wild type (WT), DNMT1 
knock-out (MT1KO), DNMT 3b knock-out 
(3bKO) and DNMT1 plus DNMT3 knock-out 
(3DKO), displaying HpaII/Msp1 coefficient on the 
upper graph and HpaII/EcoRI coefficient on the 
lower graph. Adapted from “M. Karimi et al., 
“LUMA (Luminometric Methylation Assay)-A high 
throughput method to the analysis of genomic DNA 
methylation” Exp. Cell Res., 2006.” 
Fig. 22- An example of a final COBRA 
end product. The bisulfite conversion 
applied will create different restriction 
zones for BstUI, resulting in two different 
molecular sized fragments that will 
separate under electrophoresis. The 
intensity of the stain shows not only the 
presence of methylation but its quantity. 
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5.11. Illumina Methylation Assay 
 
The Illumina Infinium Methylation Assay is a bead-based assay technique that uses 
bisulfite conversion and beads containing primers for over 850,000 methylation sites [102], 
both for methylated and unmethylated variants in Infinium I and a single primer for each 
location in Infinium II that stops one base before the methylation location, in the Infinium 
MethylationEPIC Kit, alongside single-base extension using labeled ddNTPs in order to 
develop the data.  
The workflow begins with a bisulfite conversion, followed by an amplification and 
fragmentation of the converted DNA, which is then incubated in the assay’s chip. During 
incubation, DNA is denatured and bound to the primer beads, to which is then added labeled 
ddNTPs for the single base extension. The results come out as an array as seen in Fig. 23, 
which can be read by array scanners and have data automatically processed by Illumina’s 
proprietary software [103].  
 
Fig. 23- The resulting array of an Illumina Infinium Assay, each dot representing a distinct 
methylation point, with the possible results of green for unmethylated locations, red for 
methylated locations and yellow for locations with intermediate levels of methylation. 
Adapted from “Illumina, “Infinium HD Methylation Assay Protocol Guide (15019519)” 
no. November 2015.” 
 The assay covers 99% of human Refseq genes, 95% of human CpG Islands, and 
ENCODE enhancer regions [104], at a single nucleotide resolution, across the entire genome 
[102], making it viable for both biomarker methylation assessment and inducing information 
about global at the same time. 
 
5.12. LC-MS/MS  
 
Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is a 
small molecule quantitative/qualitative combo technique that combines the separation power 
of liquid chromatography with the mass analysis power of mass spectrometry. Liquid 
chromatography is a technique that is able to separate many different components in a short 
amount of time by using a changing mobile phase against a stationary phase to elute the 
particles through several possible characteristics like particle size, particle charge, the 
particle’s solute properties, etc. In this case, DNA that underwent complete lysis until 
nucleotides were completely separated, would then be separated and leave the elution tower 
at different times, with methylated cytosines leaving at a slightly different time than 
unmethylated cytosines. 
Right after leaving the elution tower, the circuitry continues directly into the mass 
spectrometer. Right before entering the machine, the particles are ionized by an ion source, 
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required for the mass spectrometer to be able to magnetically separate the particles by mass 
per charge. Once separated, a single ionized particle is fragmented through Collision-
induced dissociation, on which the particle is accelerated and collided with a neutral gas, 
such as noble gases. These fragments have a predictable mass per charge, meaning a cytosine 
would always produce a certain type of fragments while a methylated cytosine would 
produce slightly different particles. These fragments undergo another mass per charge 
separation and are then detected right after the first pass, creating the tandem effect. This 
amplifies the technique’s sensitivity and ability to differentiate between very similar 
particles, a trait necessary due to the fact that the nucleotides that constitute the DNA create 
roughly similar fragments as well as the minor difference between methylated cytosines and 
unmethylated cytosines (Fig. 24) [105]. 
 
 
Fig. 24- LC-ESI-MS/MS chromatogram acquired by Song et al.’s pilot test obtained by 
testing 1ng of each nucleotide and variants through a standard LC-MS/MS protocol. 
Adapted from: “L. Song, S. R. James, L. Kazim, and A. R. Karpf, “Specific method for the 
determination of genomic DNA methylation by liquid chromatography-electrospray 
ionization tandem mass spectrometry” Anal. Chem., vol. 77, no. 2, pp. 504–510, 2005.” 
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5.13. Choosing a technique 
 
With so many options at our disposal, each vastly different from the others, one must 
take into consideration the technique’s strengths, weaknesses and the rigor needed for 
forensic usage.  
Before delving into them, these techniques all have different applications. 
Techniques can excel in global methylation data, specific loci or a broad arrange of loci. 
LUMA, MeDIP, LC-MS/MS, ELISA based assays and COBRA assays are great for global 
DNA methylation data, while Bisulfite Pyrosequencing, MSP and Illumina methylation 
assays shine when it comes to providing gene specific methylation status, albeit Bisulfite 
Pyrosequencing could be used to mirror global methylation status as a surrogate if used to 
measure the methylation status of LINE-1. This means that to use global methylation as an 
internal standard for the PMI assessment, two techniques would be required, save for 
Bisulfite Pyrosequencing. 
To make a choice, one must take into consideration the forensic scenario. Two 
possibilities exist in this case: all but small blood splatters were found and sampled, and it 
may be needed to know how old those splatters are to position the crime in a time frame; or 
a body was found, time of death is needed and there is no shortage of input DNA. When 
reaching an accredited laboratory for testing, the samples may be degraded in the case of a 
decomposing body recovery; in low quantity per sample, often under 10ng in the cases of 
blood splatters [106]; or in high quantities of different samples, many blood splatters around 
the body as an example, under the expectancy of a fast and precise turnaround of results. 
Many of the standard protocols for many of the techniques require DNA in both pristine 
quality and around the 1µg mark of quantity (Table 3), and, while in the presence of a body 
with ample DNA for testing all of the listed techniques are viable, very few provide solid 
data when provided little input DNA in the case of a missing body. The only technique that 
can be used with completely degraded DNA is the Liquid chromatography coupled with 
tandem mass spectrometry, as it requires no bisulfite conversion and relies on complete 
disassociation between all the DNA’s nucleotides. It is also one of the very few global 
methylation accessing methodologies that doesn’t require high quality DNA alongside, 
when considering the setting, high amounts of DNA to obtain acceptable levels of reliability. 
Methodologies that target specific loci, or an array of loci, generally can handle DNA with 
some degradation, some with very low quantities of DNA, being good news when 
considering the creation of a battery of biomarkers for forensic usage will require techniques 
that can target different loci with sparse, damaged DNA. Finally, considering that an internal 
sample control like global methylation may be required to normalize all the results, it seems 
to become more likely that more than one technique may be required for the process of PMI 
assessment, lest LINE-1 methylation perform acceptably as a surrogate or another way of 
normalizing the results within a certain technique is found viable.  
One variable to also take into consideration when choosing a technique is the cost. 
This is highly subject to change, from technique to technique, from laboratory to laboratory, 
but when presented with a new emerging industry, in this case forensic epigenetic testing, 
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the prices tend to go down from the current research focused market, either through the 
establishment of grants, optimization of kit manufacturing when prompted with a higher 
product demand, increased competitivity, etc., as seen by the example of the  
commercialization of whole genome sequencing as the next generation sequencing 
technology matured.  
 
Table 3- Comparison between several DNA methylation accessing techniques. Data 
partially adapted from “S. Kurdyukov and M. Bullock, “DNA methylation analysis: 
Choosing the right method” Biology (Basel)., vol. 5, no. 1, pp. 1–21, 2016.” [107] and “E. 
Olkhov-Mitsel and B. Bapat, “Strategies for discovery and validation of methylated and 
hydroxymethylated DNA biomarkers” Cancer Med., vol. 1, no. 2, pp. 237–260, 2012.” 
[84]. 
 
Technique Group 
Amount of DNA 
Required 
Quality of DNA 
Required 
Global DNA methylation techniques (sequencing) 
Restriction landmark 
genomic scanning 
(RLGS) 
Restriction enzyme 
digestion 
~7µg [108] High 
HpaII tiny fragment 
Enrichment by 
Ligation-mediated 
PCR (HELP-seq) 
1µg [96] High 
Methyl-seq ~3µg High 
Luminometric 
Methylation Assay 
(LUMA) 
500ng to 250ng High 
Methylation-sensitive 
cut counting (MSCC) 
5µg to 1µg High 
Methylated CpG 
island amplification 
(MCA-seq) 
5μg [109] High 
Methylated DNA 
immuno-precipitation 
(MeDIP-seq) 
Affinity-based 
1µg to 100ng [110] High 
Methylated CpG 
island recovery assay 
(MIRA) 
1µg to 1ng [111] High 
Whole genome 
shotgun bisulfite 
sequencing  
(WGSGS) 
Bisulfite 
Conversion 
10ng [112] High 
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Reduced 
representation bisulfite 
sequencing 
(RRBS) 
Bisulfite 
Conversion 
~1µg High 
Denaturing HPLC 
(DHPLC) 
100ng to 10ng 
[113] 
Medium 
Liquid 
chromatography 
coupled with tandem 
mass spectrometry 
(LC-MS/MS) 
1µg to 4ng Low 
Global DNA methylation techniques (microarray) 
HpaII tiny fragment 
Enrichment by 
Ligation-mediated 
PCR (HELP)  
Restriction enzyme 
digestion 
1µg [96] High 
Methylated CpG 
island amplification 
microarray 
(MCAM) 
5μg [109] High 
Methylation 
amplification DNA 
chip (MAD) 
1μg [114] High 
Promoter-associated 
methylation 
amplification DNA 
chip (PMAD) 
0.5μg [115] High 
Comprehensive high-
throughput arrays for 
relative methylation 
(CHARM)  
3.5μg [116] High 
Microarray-based 
methylation 
assessment of single 
samples (MMASS)  
2μg (v1); 1.2μg 
(v2) [117] 
High 
Differential 
methylation 
hybridization (DMH) 
200ng to 100ng 
[118] 
High 
Methylation single-
nucleotide 
polymorphism 
(MSNP) 
Restriction enzyme 
digestion 
600ng [110] High 
Methylated DNA 
immuno-precipitation 
(MeDIP)  
Affinity-based 1µg to 100ng [110] High 
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Many of the listed techniques and technologies have the possibility to undergo 
optimization for the low quantities of possible available DNA, but if taking into 
consideration the current standard protocols, the techniques most close to being able to adapt 
to such low input DNA quantities that might be available in the cases of missing body are: 
LUMA; MeDIP; MIRA; WGSGS; DHPLC; LC-MS/MS; PMAD; DMH; MSNP; ELISA 
Methylated CpG 
island recovery assay 
(MIRA) 
Affinity-based 
3μg to 2μg [119] High 
Enzyme-linked 
immunosorbent assay 
(ELISA) 
2μg to100ng High 
Bisulfite methylation 
profiling (BiMP) 
Bisulfite 
Conversion 
2μg to100ng [120] High 
Specific Loci Methylation techniques 
Bisulfite Sequencing 
Bisulfite 
Conversion 
~1μg [121] Medium 
Bisulfite Padlock 
Probes  
~200ng [122]  Medium 
Bisulfite 
Pyrosequencing 
~1μg [123] Medium 
Methylation-specific 
PCR (MSP) 
100ng to 50pg 
[124] 
Medium 
Sensitive melting 
analysis after real-time 
methylation-specific 
PCR (SMART-MSP) 
1ng [125] Medium 
Methylation-specific 
fluorescent amplicon 
generation (MS-
FLAG) 
1μg [126] Medium 
Combined bisulfite 
restriction analysis 
(COBRA) 
Bisulfite 
Conversion / 
Restriction enzyme 
digestion 
2μg [127] Medium 
Methylated DNA 
immunoprecipitation 
PCR (MeDIP-PCR) 
Affinity-based 1µg to 100ng [110] Medium 
Combination of 
methylated DNA 
precipitation and 
methylation-sensitive 
restriction enzymes 
(COMPARE-MS) 
Affinity-based / 
Restriction enzyme 
digestion 
100ng to 4ng [128] Medium 
Illumina Infinium 
Methylation Assay 
Affinity-based 250ng High 
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based assays; BiMP; Bisulfite Padlock Probes; Bisulfite Pyrosequencing; MSP; SMART-
MSP; MeDIP-PCR; COMPARE-MS; Illumina Infinium Methylation Assays. In that group, 
those that can handle slightly degraded DNA in their current level of optimization are: 
DHPLC; LC-MS/MS; Bisulfite Padlock Probes; Bisulfite Pyrosequencing; MSP; SMART-
MSP; MeDIP-PCR; COMPARE-MS. While LUMA and Infinium Methylation assays suffer 
slightly from DNA degradation, they are respectfully powerful techniques that should not be 
entirely disregarded. The Infinium assays cover incredibly large amounts of the human 
genome in a quick and succinct protocol, albeit being quite expensive per sample. LUMA is 
one of the few global methylation techniques capable of utilizing low amounts of input DNA 
that don’t require expensive hardware to perform, in the form of a mass spectrometer, being 
a good candidate in lieu of the strong LC-MS/MS. 
 As the methodology is still in its early years of infancy, reaching a concrete decision 
on the best technique to use is difficult. The size of the biomarker battery, lack of 
optimization for low input DNA, price range changes, possible reaction kit developments, 
volume of samples per case and other variables yet unknown may cause discarded techniques 
to become viable. With current knowledge, the frontrunners for viability are LUMA, LC-
MS/MS, MSP and SMART-MSP, Bisulfite Padlock Probes, MeDIP-PCR and Infinium 
Assays, in no particular order. Alongside techniques that use PCR, HRM analysis is also a 
front to be studied that can easily compliment them and provide further information. 
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6. The State of the Art 
 
6.1. Lessons from the RNA based PMI assessment efforts 
 
While designing a protocol to determine PMI through genetic information, one must 
take into consideration the molecule to work with. RNA and DNA are vastly different 
molecules with different properties that bring with them different problems that need to be 
solved before an all-variable encompassing standard can be created for forensic use.  
The work of determining if the usage of DNA degradation in relation to PMIs can be 
traced to the decade of 1980s [129], with unfavorable results. In the following years, this 
trend did not alleviate, with research being nearly dropped in the early 2000s [130]. The 
research into the topic focused in flow cytometric evaluations, tried in several tissue samples, 
with one of the most recent being dental pulp [131]. Flow cytometry is a fluorescence-based 
technique that forces single cells through the analysis node one at a time, where a laser 
excites the fluorescent reporters the sample was stained with. Using reporters that can bind 
solely to the desired biomarker, flow cytometry can detect quantity in undamaged cells, or 
most commonly, used to analyze quantitively and qualitatively cells, if used cell specific 
reporters.  
Even notwithstanding the poor to no linearity of the results obtained through such 
protocols [130], the decisive fact that made such usage impossible was that after 72h mass 
DNA denaturation settled in on most tissues, making any scalability of the protocol very 
unlikely. So, after no progress having been achieved in this front, efforts shifted to another 
form of genetic material. 
 Focus on RNA degradation as a tool for PMI estimation in a forensic setting was 
piloted by Martin Bauer et al. in 2003 [10]. In this study, fatty acid synthase-messenger RNA 
(FASN-mRNA), an mRNA tied to a housekeeping gene, therefore present across time and 
tissue, with a size of roughly 10 kb was compared between fifty freshly drawn blood 
samples, fifty blood samples drawn and 36 brain samples from cadavers with exact time of 
death known. As for the theory, the study opted to access the degradation from the 5’ end of 
the mRNA, using four distinct primers that annealed to it at areas roughly 1.5 kb apart, each 
requiring a different amount of the molecule to be intact in order to form fragments (Fig. 
25).  
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Fig. 26- The mean values for the quotient between FASN1 and FASN 4 from 10 blood 
samples taken from living individuals, ranging from immediate processing to three days of 
4ºC storage (Left). The scatterplot plotting each postmortem’s brain sample’s ratio 
between FASN1 and FASN4 against time passed since death (Right). Adapted from M. 
Bauer, I. Gramlich, S. Polzin, and D. Patzelt, “Quantification of mRNA degradation as 
possible indicator of postmortem interval - A pilot study” Leg. Med., vol. 5, no. 4, pp. 220–
227, 2003. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As for the workflow, it consisted a concise four step process of extraction, 
purification, amplification and analysis. The focal part of this study’s laboratorial work was 
the qPCR. After the FASN-mRNA being converted into cDNA, each sample and each primer 
were amplified in separate tubes in the same qPCR, which negated possible discrepancies 
between results (Fig. 26). Such results also substantiated through ultra-thin polyacrylamide-
gel electrophoresis. 
 
 
 
 
 
 
 
 
 
 
Fig. 25- Primer setup used to determine mRNA degradation. The further stages of overall 
molecular degradation, the less the number of fragments created by FASN 1, FASN 2 and 
FASN 3. The bigger the difference between the amount of FASN 4 fragments, that stood 
near the protected poly-A chain, away from the degraded 5’ end, and each of the other 3 
primers, the more advance the mRNA degradation was, in a quantifiable way. Adapted 
from M. Bauer, I. Gramlich, S. Polzin, and D. Patzelt, “Quantification of mRNA 
degradation as possible indicator of postmortem interval - A pilot study” Leg. Med., vol. 5, 
no. 4, pp. 220–227, 2003. 
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These results obtained from postmortem blood samples were but a fraction of the entire 
sampling, as 25 of the samples, half of the total drawn, were unable to produce any results 
due to the advanced stage of hemolysis. Although the successful samples produced a steady 
decrease of FASN1/FASN4 quotient, as seen in the left part of Fig. 26, with a reported strong 
correlation (r = 0.808; P < 0.01), the fact that half the samples did not produce usable results 
puts a strong damper on the usage of blood mRNA for forensic procedures. Also, when the 
quotients for more inner FASN primers is 
analyzed, the downward pattern diminishes, 
vanishing on the FASN3/FASN4 quotient (Fig. 
27), thus limiting any possible PMI calculations 
to the FASN1/FASN4 quotient, or the quotient 
between the most distal and proximal areas 
relative to the protected poly-A chain in other 
mRNA molecules. Brain samples on the other 
hand provided a much more robust success rate 
in obtaining results but shared the same issue 
as blood sample results of losing the downward 
pattern the closer the FASN primers were. 
Another issue with the protocol is the fact that 
live blood samples had their mRNA 
degradation slowed by storing them at 4ºC 
instead of room temperature, meaning the 4 to 
5 day period tested and window of scalability will become much shorter once the mRNA is 
allowed to degrade at its usual rate. This also points towards the temperature of the body 
being a heavy variable in mRNA degradation PMI estimation, and the variations it suffers 
due to the various postmortem stages a body goes through, as well as daily temperature 
cycles, may turn creating a standard very difficult. 
 The temperature induced error margins have been since worked on and in 2016, Ye-
Hui et al. tackled this issue [16]. The study followed a similar laboratorial procedure as 
Bauer’s one, extraction, purification, amplification and analysis but with a much heavier 
emphasis on the data analysis. It started with 216 rats, divided into three major groups 
postmortem, kept at 10ºC, 20ºC and 30ºC, with each major group being divided further by 
PMIs (0h, 1h, 3h, 6h, 12h, 24h, 36h, 48h, 72h, 96h, 120h, 144h), in which tissue samples 
from the liver and muscle were retrieved and used to create a mathematical model that could 
be used to determine PMI. Fifteen other rats were separated into five major groups 
postmortem, ranging from 10ºC to 30ºC in intervals of 5ºC, with liver and muscle samples 
taken at 10h, 60h and 110h postmortem. This set of rats were used as checks against the 
mathematical model to substantiate it. Twelve postmortem lung and muscle tissue samples 
were also obtained from humans at the time of autopsy, with clear time of death, PMI 
including time passed while under freezing conditions at the morgue, and temperature 
assumed to be the average of the crime scene before the transfer of the body.  
Fig. 27- The scatterplot denoting the 
FASN3/FASN4 quotient off all 
postmortem blood samples. Adapted from 
M. Bauer, I. Gramlich, S. Polzin, and D. 
Patzelt, “Quantification of mRNA 
degradation as possible indicator of 
postmortem interval - A pilot study” Leg. 
Med., vol. 5, no. 4, pp. 220–227, 2003. 
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Four different classes of RNA molecules were chosen to be potential targets for the 
mathematical model’s variable or for reference, these being: 18S rRNA and 5S   representing 
ribosomal RNAs, RPS29, ACTB and GAPDH standing in for messenger RNAs, let-7a, miR-
195, miR-200c, miR-1 and  miR-206 on behalf of micro RNAs, and the small nuclear RNA 
U6 .  
After successful RNA extraction, isolation, and amplification by qPCR on all 
samples, all data was processed with the aid of geNorm, an algorithm that can be used to 
determine the most stable reference gene or genes from the qPCR results of the entire set of 
studied RNAs. The algorithm calculates the M-value, the relative stability of all appointed 
reference samples in the processed set in accordance with Vandesompele et al., Genome 
Biology, 2002, 'Accurate normalization of real-time quantitative RT-PCR data by geometric 
averaging of multiple internal control genes' [132]. Analysis has shown that the 
housekeeping ACTB and GAPDH were the most unstable RNAs and most prone to 
degradation (Fig. 28), while 5S and RPS29 could be used as internal reference biomarkers 
for lung tissues and control markers for muscle tissues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mathematical model itself was constructed using the ΔCt values obtained in the 
qPCR. The Ct value is the number of PCR cycles a sample’s fluorescence required to surpass 
the threshold set to ignore background fluorescence.  This value is inversely proportional to 
the amount of initial target genetic sample, meaning the bigger the number of molecules in 
the initial sample, the lower the Ct value will be. In this study, the target genetic sample that 
can provide a successful duplication in a cycle is the non-degraded RNA molecules in the 
sample. Following the same logic, the lesser the overall RNA degradation is, the more 
molecules can provide a successful duplication and the lower the Ct is. The ΔCt values are 
the difference between the Ct values of the chosen target biomarkers, ACTB and GAPDH, 
Fig. 28- Mean M-values in lung tissue samples from rats kept at 20ºC, from all PMIs tested 
(Left). Mean M-values in human postmortem lung tissue samples used for model 
validation (Right). ACTB and GAPDH possess the highest values in both sets of data, 
indicating that from all the tested biomarkers they’re the ones most prone to bigger 
differentiation of degradation along PMIs. miR-195, miR-200c, 5S, U6 and RPS29 showed 
low M-values, being selected as reference biomarkers for the creation of the mathematical 
model. Adapted from Y. H. Lv et al., “RNA degradation as described by a mathematical 
model for postmortem interval determination” J. Forensic Leg. Med., 2016. 
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and the geometrical Ct values of the reference biomarkers, miR-195, miR-200c, 5S, U6 and 
RPS29 (Fig. 29). At 20ºC, the produced curves fit a nearly straight line with a positive slope, 
indicating a linear divergence between the Ct values of ACTB and the reference biomarkers, 
as expected. ACTB is more unstable, therefore will degrade much quicker and will generate 
a bigger Ct value much quicker than the reference biomarkers. At 30ºC the linearity isn’t as 
strong, and the positive slope is lost in the quadratic and cubic curve fits at around 108 hours. 
This loss of a linear relation may indicate the break point where the model loses its 
effectiveness.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Once the model was created, the 
samples stored at the 10ºC to 30ºC in 5ºC 
intervals were compared  to it, with the 
results being displayed in (Fig. 30). The 
results show that early on, at 10h there is 
the highest error rates at a mean of 
12.12%, followed by lower error rates at 
110h at a mean of 6% and having the 
lowest error rates at the 60h mark at a 
mean of 4.12%, with lung samples being 
more accurate than muscle samples by a 
difference of 1.7%. The previously noted 
Fig. 29- Curve fit of postmortem rat lung tissue samples kept at 20ºC between ACTB ΔCt 
and PMI (Left). Curve fit of postmortem rat lung tissue samples kept at 30ºC between 
ACTB ΔCt and PMI (Right). Adapted from Y. H. Lv et al., “RNA degradation as described 
by a mathematical model for postmortem interval determination” J. Forensic Leg. Med., 
2016. 
Fig. 30- Cross reference between the 
mathematical model and rat sample used for 
validation’s results. Adapted from Y. H. Lv et 
al., “RNA degradation as described by a 
mathematical model for postmortem interval 
determination” J. Forensic Leg. Med., 2016. 
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loss of positive relation in the model explains the decreased accuracy at 110, while early on 
there might not be enough difference between the target and refrence biomarkers for the 
model to be accurate, meaning that an internal refrence normalized mathematical model 
might be restricted to a certain time frame for maximum accuracy.  
The insight that the variation of the RNA models is great between temperatures but 
can be mitigated using stable biomarkers as internal references Ye-Hui’s work provided is 
very key insight that will inevitably be required if a standard for forensic usage is to be 
created using DNA methylation. As many other variables might affect DNA methylation  
alongside temperature, the usage of a gene with a long term stability in its methylation that 
has suffered all the same variations as the more unstable target gene’s epigenetic in order 
anchor the data may be the key to create a robust, all-encompassing methylation standard 
for forensic usage, even though if maximum accuracy may only be achieved in a certain 
timeframe depending on the combination of reference and target biomarkers. 
 
6.2. Work in the Epigenetics Front 
 
Work on the epigenetic side is a relatively more recent endeavor, at least on the 
forensics front. Postmortem DNA methylation status has been a hot topic of research in 
neurobiology and medical fields since the late 2000s. Deregulation of DNA methylation has 
been linked to major psychosis [133]–[135], hinted at a possible link in major depressive 
disorder [136] and sporadic amyotrophic lateral sclerosis [137]. While a many of these 
papers provide information on postmortem DNA methylation status, even if focusing on a 
few genes, none published yet focuses on measuring PMI directly using it.  
Nonetheless, the basis for this field of work are being currently built by such studies. 
Much of the information given is crucial for the precision of the standard. Marie-Abele Bind 
et al. [138] studied DNA methylation on in-vivo blood samples from 777 elderly participants 
of the normative aging study, focusing on long interspersed nuclear element (LINE-1), Alu 
and tissue factor 3 (F3), intercellular  adhesion  molecule  1 (ICAM-1), toll-like receptor 2 
(TLR-2), carnitine O-acetyltransferase (CRAT), 8-oxoguanosine DNA glycosylase-1 
(OGG1), interferon gamma (IFN-γ), glucocorticoid receptor (GCR) and inducible nitric 
oxide synthase (iNOS) genes, measuring methylation at 1-5  CpG base positions  on each of 
the promoter regions. Such genes were chosen due to their relation to pathways in turn 
related to adverse effects of high temperature and humidity in elderly populations, including 
such as coagulation and inflammation. Through bisulfite pyrosequencing, the methylation 
status of ICAM-1 over three weeks for each participant was plotted against temperature and 
humidity (Fig. 31). This graph shows that with the decrease of temperature, ICAM-1 suffers 
hypomethylation in the period of 3 weeks, and vice versa for the increase of temperature, 
and suffers hypomethylation under high humidity, with greater variation the greater the 
temperature is. The other studied genes also presented changes in methylation with 
variations in temperature and humidity. A decrease of temperature caused a CRAT 
hypermethylation, an iNOS and GCR hypomethylation after air pollution normalization and 
temperature increases caused a TLR-2 hypomethylation. Alongside that, higher relative 
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humidity produced LINE-1 
hypomethylation and Alu 
hypermethylation, with effects being 
compounded by temperature changes as 
well. This study’s results, albeit being 
taken from in-vivo samples, hint at the 
fact that epigenetic information on some 
genes may be more fluid than expected. 
Small but statistically sound variations 
occurred in a 3-week window period 
with changes as small as 5ºC per week, 
reinforcing the notion that Ye-Hui et 
al.’s [16] efforts to normalize 
temperature variations effects are 
necessary to be carried over and applied 
to epigenetic information.  
  
 
As epigenetics regulate gene expression, different tissues will also possess different 
DNA methylation values at certain genes and may degrade at different rates. Barrachina et 
al. [139] studied DNA methylation degradation in postmortem brain tissues with different 
PMIs to a maximum of 20 hours and a maximum of 48 hours in storage, alongside several 
neurologic pathologies, ranging from several stages of Alzheimer’s disease, Parkinson’s 
disease and Dementia with Lewy’s Bodies, in order to determine if postmortem delays in 
sample analyzing  affected the validity of DNA methylation relations to such diseases. The 
study proceeded with 124 samples, from which 26 controls, 27 Alzheimer disease patients 
from stage III to stage VI, 10 argyrophilic grain disease patients, 6 patients with 
frontotemporal lobar degeneration linked to tau mutations, 4 patients with frontotemporal 
lobar degeneration with ubiquitin-immunoreactive inclusions, 3 patients with 
frontotemporal lobar degeneration with motor neuron disease, 3 Pick disease patients, 8 
Parkinson disease patients and 20 patients with dementia with Lewy bodies. The methylation 
status data gathering was confined to the promoter regions of the receptor for advanced 
glycation end products (RAGE), adenosine A2A receptor (ADORA2A) and microtubule-
associated protein tau (MAPT) genes, genes linked to the pathologies included in the sample 
population. The epigenetic information was studied through bisulfite conversion followed 
Fig. 31- The 3D representation of the 3-week 
methylation status of the ICAM-1 gene against 
humidity and temperature using a 2-covariate 
penalized thin plate spline. Adapted from “M. A. 
Bind et al. “Effects of temperature and relative 
humidity on DNA methylation” Epidemiology, 
2014”. 
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by PCR amplification and time-of-flight matrix-assisted laser desorption/ionization 
(MALDI-TOF), a three-step mass spectrometry analysis protocol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The results from the tree studied locations showed stability across most CpG sites 
across all PMI (Fig. 32), either suggesting that these three genes may be stable candidate 
biomarkers or that the brain tissue is a stable enough candidate for sample collection. The 
first conclusion would have the issue that these three biomarkers are linked to pathologies, 
but the second could prove very useful. Monoranu et al. [140] continued the work on this 
front with brain samples from patients that died of causes unrelated to neurological 
pathologies and found out that methyltransferase activity, not DNA methylation itself, 
remains largely preserved along the PMIs before storage.  
 Ernst et al. [141] studied the effects that pH might have on postmortem brain tissue, 
selecting the rRNA gene and the neurotrophic receptor tyrosine kinase 2 (NTRK2) gene. 
Twenty patients’ postmortem brain samples were used, ten from the hippocampus for rRNA 
testing and twenty from the frontal cortex for NTRK2 testing. The methylation status of 
these genes was studied through bisulfite conversion followed by PCR, and subsequent 
Fig. 32- Graph plotting the 
percentage of methylation in 
different CpG sites of the 
studied gene’s promoter 
regions. All three cases, RAGE 
(top), ADORA2A (middle), 
and MAPT (bottom) show little 
to no variation between 
different PMIs. Adapted from 
“M. Barrachina and I. Ferrer, 
“DNA methylation of 
Alzheimer disease and 
tauopathy-related genes in 
postmortem brain” J. 
Neuropathol. Exp. Neurol., vol. 
68, no. 8, pp. 880–891, 2009.”. 
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integration in a pDrive cloning vector, cloned through competent Escherichia coli cells and 
sequenced. The results came as no relation between pH and rRNA methylation and negligent 
relation between pH and NTRK2, results that should be taken as merely preliminary due to 
the low number of samples and tested biomarkers (Fig. 33). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
DNA methylation stability is another variable to take into consideration. The DNA 
molecule itself is quite resilient in some tissues, even remaining usable once only skeletal 
remains are left [106] and the methylation itself is stable for roughly 48h as stated previously. 
Large term stability in a decomposing body has not yet been studied, which is the crucial 
question that will solidify the viability of a DNA methylation PMI accessing methodology, 
but long-term stability in storage was. Li et al. [142] took several samples of blood taken up 
to 20 years prior to the study, stored in 4ºC, -20ºC and -80ºC. The samples were grouped as 
such: Group 1 contained six 20-year-old DNA samples stored at 4ºC; Group 2 contained the 
same samples, but diluted 13 years later to 10ng/μl, kept at 4ºC; Group 3 contained six whole 
blood samples from the same donators of Group 1, kept with anticoagulants and stored at      
-80ºC until DNA extraction 20 years after sample collection; Group 4 contained five samples 
collected from the same donators as the Group 1, but collected 19 years more recently 
proceeding a recall, with DNA stored for less than 3 months at -20ºC; Group 5 contained 
five samples equal to Group 4, but stored at 4ºC. Each sample had its methylation profiled 
through bisulfite conversion preceding reduced representation bisulfite sequencing (RRBS), 
with a total of 33 DNA libraries, five of them replications of Group 1, Group 2 and Group 3 
samples for variance control. The resulting sequence data was matched and compared to the 
hg19 human genome reference and the methylation rate was calculated as the percentage of 
unmethylated cytosines in each CpG location, with each site being covered by at least 10 
reads. The entirety of CpG methylation data was examined for five groups of interest: CpG 
Islands (CGI), CGI Shores, transcription start sites (TSS), promoters and gene bodies. All 
comparisons between each group of interest of each sample and each group was done using 
ComBat-adjusted hierarchical clustering analysis (HCA), adjustment required due to present 
Fig. 33- Graphs plotting the frequency of methylation per clone against pH of rRNA (left) 
and NTRK2 (right). Adapted from “C. Ernst, P. O. McGowan, V. Deleva, M. J. Meaney, 
M. Szyf, and G. Turecki, “The effects of pH on DNA methylation state: In vitro and post-
mortem brain studies” J. Neurosci. Methods, vol. 174, no. 1, pp. 123–125, 2008.” 
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sequencing batch bias shown by initial methylation data, where samples from the same group 
would cluster together. When data from the subject from groups 1 to 3 were analyzed 
together, same individuals in different storage conditions, it was found that methylation 
levels were highly correlated (CGI:0.995; CGI Shore: 0.985; Gene Body: 0.973; Promoter: 
0.982; TSS: 0.988) between the same individual in different groups, across all groups of 
interest, and also that different subjects in the same group had high correlation between all 
groups of interest (Fig. 34). These results suggest that even with different storage conditions, 
with variable temperatures and different extraction times, methylation profiles of each 
subject were kept similar after 20 years.  
 
 
Fig. 34- Resulting boxplots using ComBat-adjusted methylation profiles of the DNA 
samples,  presenting correlation coefficients for same subject in different groups 
(Intergroup) and different subjects in the same group (Intragroup), across all 5 groups of 
interest. Adapted from “Y. Li, X. Pan, M. L. Roberts, P. Liu, and A. Theodore, “Stability of 
global methylation profiles of whole blood and extracted DNA under different storage 
durations and conditions” vol. 10, pp. 797–811, 2018.”. 
 
When groups one through three where compared to groups four and five, samples with 
different storage times, it was also found that methylation levels were highly correlated 
between the same individual in different groups and between different individuals in the 
same groups (Fig. 35). These results suggest that methylation profiles don’t change 
statistically significantly over periods of up to 20 years in storage when compared against 
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newer samples from the same individual, meaning that these samples are still valid samples 
that provide accurate data.  
 
 
 
 
 
 
 
 
 
 
 
 
To study if the presence of chemicals for large periods of time affected the methylation 
profiles, groups three and four, samples stored in Acid-citrate-dextrose vacutainers, were 
tested against each other. Methylation profiles across different subjects in the same group of 
both groups showed high correlation again (CGI: 0.990 G3/ 0.990 G4; CGI Shore: 0.984 
G3/ 0.981 G4; Gene Body: 0.977 G3/ 0.966 G4; Promoter: 0.975 G3/ 0.971 G4; TSS: 0.978 
G3/ 0.974 G4). Such similarities between the methylation profiles suggest that the presence 
of anticoagulants does not interfere with DNA methylation, or that if it does, the changes in 
pattern are changed in a reliable way. Finally, it was tested if different anticoagulants had a 
different effect on methylation. Groups 4 and 5 had their samples stored with Acid-citrate-
dextrose (G4) and EDTA (G5), for a period of three months. Here the data shows a slightly 
smaller correlation (G4- CGI: 0.988; CGI Shore: 0.974; Gene Body: 0.955; Promoter: 0.960; 
TSS: 0.970 / G5- CGI: 0.988; CGI Shore: 0.983; Gene Body: 0.975; Promoter: 0.967; TSS: 
0.973). This implies that different anticoagulants may affect the DNA methylation profiles 
slightly in different ways, inferring that anticoagulants do interfere with the methylation 
profiles in reliable ways. 
Li et al.’s findings have preliminarily found that methylation profiles are kept stable 
under controlled storage conditions for very long periods of time and diverse amounts of 
thawing and refreezing processes, yet the crux for the viability of an epigenetic PMI assessor 
is the stability under uncontrolled conditions. Bulla et al. [143] tackled most of the same 
points as Li et al., with the addition on room temperature. Eight subjects donated 41 blood 
samples, kept under different storage conditions. Each subject had their 41 samples divided 
into three groups: Group 1 consisted in EDTA whole blood samples without any additives; 
Fig. 35- Benjamin–Hochberg-adjusted false-discovery rate of pair-wise 
Wilcoxon rank-sum test of correlation coefficients between methylation profiles 
of DNA samples amongst all groups. Adapted from “Y. Li, X. Pan, M. L. 
Roberts, P. Liu, and A. Theodore, “Stability of global methylation profiles of 
whole blood and extracted DNA under different storage durations and 
conditions” vol. 10, pp. 797–811, 2018.”. 
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Group 2 consisted in EDTA whole blood samples with one quarter of DNAgardBlood 
solution per volume, added before storage; Group 3 consisted in EDTA whole blood samples 
with one quarter of DNAgardBlood solution per volume, added after storage, right after 
thawing, before samples were processed. For each group, various samples were stored at 
different temperatures and processed at different times (Table 4). 
 
Table 4- Division of samples by group and time in storage. RT: Room Temperature. Data 
adapted from “A. Bulla, B. De Witt, W. Ammerlaan, F. Betsou, and P. Lescuyer, “Blood 
DNA Yield but Not Integrity or Methylation Is Impacted after Long-Term Storage” 
Biopreserv. Biobank., vol. 14, no. 1, pp. 29–38, 2016.” 
 
Group 
1 RT 
Group 
1 
(4ºC) 
Group 
1 (-
20ºC) 
Group 
1 (-
80ºC) 
Group 
2  
RT 
Group 
2 (-
20ºC) 
Group 
2 (-
80ºC) 
Group 
3 (-
20ºC) 
Group 
3 (-
80ºC) 
0h 3         
24h 1 1        
48h 1 1   1     
7 days 1 1 1 1 1 1 1 1 1 
14 
days 
1 1 1 1 1 1 1 1 1 
6 
months 
 1 1 1 1 1 1 1 1 
12 
months 
  1 1 1 1 1 1 1 
 
From each sample, DNA quality, DNA yield and DNA methylation were assessed. DNA 
yield and quality were obtained through spectrofluorometry (Quant-iT PicoGreen dsDNA 
Assay Kit) and spectrophotometry (NanoDrop 3000). The three room-temperature, 0h Group 
1 samples were used as control samples. DNA methylation was assessed through post-
restriction enzyme MSP (Epitect Methyl II PCR Arrays Kit). The compared groups were 
Group 1 at -20ºC, Group 1 at 80ºC and Group 2 at room temperature. All statistical data was 
obtained through Kruskal–Wallis test accompanied by Dunn’s multiple comparison 
subsequently. In the spectrophotometric assessment of DNA yield, the 3 Group 1 samples 
tested at 0h were used as reference, ranging from 10.9mg/mL to 24.6mg/mL. The data shows 
that: Group 1 samples had a quick DNA degradation at higher temperatures, rate decreasing 
alongside temperature, losing 70% of its total yield at room temperature by 2 weeks up to 
keeping 70% of its total yield at -80ºC at 12 months; Group 2 samples suffered a much lower 
DNA degradation rate across all times and temperatures, from keeping 60-80% of total yield 
at room temperature across time to stable 80% of total yield at -80ºC in up to 1 year; Group 
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3 samples had the best yields with stable 90% of total yield at both -20ºC and -80ºC in up to 
1 year (Fig. 36). 
 
 
Fig. 36- DNA yield data obtained through spectrophotometry, relative to Group 1 0h 
control samples. CV: Coefficient of Variation; EDTA: Group 1; DgB before: Group 2; 
DgB after: Group 3. Adapted from “A. Bulla, B. De Witt, W. Ammerlaan, F. Betsou, and P. 
Lescuyer, “Blood DNA Yield but Not Integrity or Methylation Is Impacted after Long-
Term Storage” Biopreserv. Biobank., vol. 14, no. 1, pp. 29–38, 2016.” 
 
In the spectrofluorometric assessment of DNA yield, the 3 Group 1 samples tested at 0h 
were used again as reference, with the yields ranging from 7.5mg/mL to 16.0mg/mL. The 
data follows a similar trend to the spectrophotometric one, with quick Group 1 loss of total 
yield rapidly in the higher storage temperatures and slowing down as the temperature fell. 
 
 
Fig. 37- DNA yield data obtained through spectrofluorometry, relative to Group 1 0h 
control samples. CV: Coefficient of Variation; EDTA: Group 1; DgB before: Group 2; 
DgB after: Group 3. Adapted from “A. Bulla, B. De Witt, W. Ammerlaan, F. Betsou, and P. 
Lescuyer, “Blood DNA Yield but Not Integrity or Methylation Is Impacted after Long-
Term Storage” Biopreserv. Biobank., vol. 14, no. 1, pp. 29–38, 2016.” 
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Group 2 and Group 3 showed higher percentages of total yield across all storage 
temperatures and times, being close to or statistically equivalent to the reference samples 
(Fig. 37).  
Such results are needed to put the following methylation data in context (Table 5). 
Twenty-two genes were tested, across Group 1 samples tested at 0h after extraction that 
served as the reference values, Group 1 samples stored at -20ºC and -80ºC for 1 year and 
Group 2 samples stored at room temperature for 1 year. The table displays each gene’s 
average methylated cytosine percentage and unmethylated cytosine percentage (Mean) and 
the standard deviation (SD). All genes appeared highly unmethylated, with the exception of 
GDF15, known as the Growth Differentiation Factor 15, a gene that codes a ligand of the 
TGF-beta [144], which appeared highly methylated. All the genes had the same levels of 
methylation percentages across groups and time hovering around the half percentile for the 
highest difference gaps. Between samples for each group, the standard deviation ranged a 
bit more, with genes like MLH1, which the encoded protein heterodimerizes with mismatch 
repair endonuclease PMS2, forming a part of the DNA mismatch repair system, the αMutL 
[145], showing merely 0.01% standard deviation across times and groups, while the gene 
Cyclin Dependent Kinase Inhibitor 1A (CDKN1A), which the encoded protein binds to and 
inhibits the activity of cyclin-cyclin-dependent kinase 2 complex, which in turn heavily 
regulates cell cycle progression at G1 [146], has shown standard deviations of up to 3.32% 
in Group 1 -80ºC storage. When merely comparing Group 1 at 0h with Group 2 and 1 year, 
the group that more, if not very, closely resembles what a forensic sample would experience 
both before and after collection from the scene of crime, the data commences to show that 
DNA methylation itself, for up to 1 year, doesn’t suffer much degradation, being a rather 
stable biomarker, even if given that fact that the tested DNA on which it resided was 
artificially preserved by DNAgardBlood solution, making the DNA methylation analysis 
much easier, or that the number of tested genes was small. 
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Table 5- Average DNA methylation of the 22 tested genes across all eight subjects. T0: 
Group 1 samples at 0h; EDTA: Group 1; DgB before: Group 2. Adapted from “A. Bulla, B. 
De Witt, W. Ammerlaan, F. Betsou, and P. Lescuyer, “Blood DNA Yield but Not Integrity 
or Methylation Is Impacted after Long-Term Storage” Biopreserv. Biobank., vol. 14, no. 1, 
pp. 29–38, 2016.” 
 
 
 On a crime scene with a missing body however, the sampled DNA can come from 
old, dried blood left behind during the offence, instead of being directly drawn and preserved 
immediately from a body. Hollegaard et al. tackled this angle somewhat by studying the 
viability of methylome screening using dried neonatal blood spot samples [147]. Two 
individuals had neonatal venous blood samples dried in pure cellulose collection cards, 
stored for 28 and 26 years until analysis (neoDBSS); venous blood drawn and analyzed at 
the ages of 25 and 23 (Reference); venous blood collected and dried on pure cellulose 
collection cards at the ages of 25 and 23 and stored at -20ºC for 3 years until analysis 
(RefDBSS). Methylome was studied through bisulfite conversion and Infinium 
HumanMethylation27, of which, from the neonatal dried blood spot samples, only 30ng of 
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DNA were used for the initial bisulfite conversion, close to the expected amount available 
in forensic samples with a missing body. Methylation data was obtained through fluorescent 
probe labeling, with a total of 27,578 probes divided as: Probe group A, red signal, 
representing unmethylated CpG locations; Probe group B, green signal, representing 
methylated CpG locations, being held against CpGenome Universal Methylated DNA 
(Millipore) as a positive control and whole-genome amplified eldest individual  before 
bisulfite treatment as negative control. Each CpG location had a β-value attributed to it, 
obtained through averaging both probe groups signals, ranging from 0 to 100% methylation 
(Fig. 38). 
 
 
Fig. 38- Graph plotting β-values of the genes that most changed between neonatal dried 
blood spot samples (light blue and light red) and adulthood dried blood spot samples (dark 
blue and dark red). Adapted from “M. V. Hollegaard, J. Grauholm, B. Nørgaard-Pedersen, 
and D. M. Hougaard, “DNA methylome profiling using neonatal dried blood spot samples: 
A proof-of-principle study” Mol. Genet. Metab., vol. 108, no. 4, pp. 225–231, 2013.” 
 
 Following such, the two used DNA extraction protocols used, Extract-N-Amp Blood 
PCR kit (ENA) and ChargeSwitch Forensic DNA Purification kit (CS), were tested for 
performance (Fig. 39). A thinner plot cloud and a more centered plot cloud around the 
theoretical ideal line represents a higher level of correlation, meaning that DNA extracted 
through ChargeSwitch Forensic DNA Purification kit (CS) showed a lesser fidelity to the 
real data, caused by an insufficient amount of extracted DNA, and caused CS-extracted 
samples to be discarded as a reliable source of data.  
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Afterwards, it was tested if the RefDBSS samples stored for 3 years were an accurate 
representation of the real methylome, represented by the Reference samples. Both ENA and 
CS samples were tested against each individual’s reference sample in a differential 
methylation analysis. ENA extracted RefDBSS of each individual presented no changes 
from the respective individual’s Reference sample’s methylome, indicating that they are 
equivalent in terms of DNA methylation, even after stored as dried blood samples for 3 years 
at -20ºC. In contrast, CS extracted RefDBSS presented several deviations from the 
correspondent Reference samples, indicating that the extraction process is once again 
unviable for such small amounts of available input DNA. 
 
 
 
 
 
Fig. 39- Signal intensity from RefDBSS samples extracted with ENA (right) and CS (left) 
kits of individual A (eldest) and individual B (youngest) plotted against the Reference 
samples. Adapted from “M. V. Hollegaard, J. Grauholm, B. Nørgaard-Pedersen, and D. 
M. Hougaard, “DNA methylome profiling using neonatal dried blood spot samples: A 
proof-of-principle study” Mol. Genet. Metab., vol. 108, no. 4, pp. 225–231, 2013.” 
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Table 6- Differential methylation analysis between reference samples and dried blood spot 
samples extracted by ENA and CS. Adapted from “M. V. Hollegaard, J. Grauholm, B. 
Nørgaard-Pedersen, and D. M. Hougaard, “DNA methylome profiling using neonatal 
dried blood spot samples: A proof-of-principle study” Mol. Genet. Metab., vol. 108, no. 4, 
pp. 225–231, 2013.” 
 
 
As RefDBSS samples are faithful representations of the methylome, they were used as the 
referenced to which the neoDBSS were tested against. Again, the comparison was done with 
a differential methylation analysis (Table 7). When checked between the same individual, 
RefDBSS and neoDBSS samples showed high similarity. Individual A neoDBSS samples 
when compared to individual A RefDBSS, presented 19 hypermethylated and 31 
hypomethylated CpG locations, with β-value means of roughly 0.33 and -0.35, translating 
to roughly 30% methylation difference in average on those locations, out of 27,578 locations. 
Similarly, individual B neoDBSS samples when compared to individual B RefDBSS, 
presented 35 hypermethylated and 16 hypomethylated CpG locations, with β-value means 
of roughly 0.34 and -0.37, translating to roughly yet again 30% methylation difference in 
average on those locations, out of 27,578 locations. When comparing both RefDBSS and 
neoDBSS of one individual to the RefDBSS of the other, its noted that the difference 
between hypermethylated and hypomethylated CpG locations mirrors the one present in the 
intra-individual analysis. Individual B neoDBSS and individual B RefDBSS samples when 
compared against individual A RefDBSS showed 89 hypermethylated and 37 
hypomethylated CpG locations, with β-value means of roughly 0.37 and -0.34. 
 
Table 7- Differential methylation analysis between ENA extracted RefDBSS samples and 
ENA extracted neoDBSS samples. Adapted from “M. V. Hollegaard, J. Grauholm, B. 
Nørgaard-Pedersen, and D. M. Hougaard, “DNA methylome profiling using neonatal 
dried blood spot samples: A proof-of-principle study” Mol. Genet. Metab., vol. 108, no. 4, 
pp. 225–231, 2013.” 
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 Hollegaard et al.’s pilot work tentatively shows that blood samples stored in pure 
cellulose disks, without any blood preservatives nor DNA stabilizers, dried and kept at -20ºC 
for over 25 years were able to provide reliable, true to reference, global methylome status 
from very small amounts of input DNA. Hollegaard et al.’s work is, however, very small in 
scale, and as such, the results are a mere test to the concept of DNA methylation stability 
postmortem, albeit one passed successfully.   
 
6.3. Obstacles to Overcome 
 
6.3.1. DNA Methylation and Pathologies  
 
One of the guidelines for the viability of a marker for forensic usage is that it must 
not be related to any pathology, as it may skew results and create doubt in the validity of the 
results. Epigenetic information regulates DNA expression and, as a result, irregularities in 
its maintenance or levels in many genes can lead to pathologies like cancer, or even be 
deregulated as collateral damage of a lifelong medication intake, has seen in the study 
performed by J. Mill et al. where it was discovered that a lifelong antipsychotic usage in 
schizophrenia patients led to a localized aberrant methylation in the MEK1 gene promoter 
region [133]. Many, many DNA methylation irregularities in certain genes haven been found 
in patients with psychological pathologies and cancers.  
Some of the known deregulated genes linked to depression are the Brain Derived 
Neurotrophic Factor (BDNF) gene, a gene that codes an important protein responsible for 
promoting neuron survival, growth, maturation and maintenance, while maintaining activity 
in synapses, presenting increased methylation [148]–[151]. The Solute Carrier Family 6 
Member 4 (SLC6A4), which codes an important serotonin membrane transporter protein 
that recycles it from the synaptic valley into the presynaptic neuron, is hypermethylated in 
Fig. 40- Relation between cancer 
progression, DNA methylation, histone 
methylation and CpG island methylation. 
As cancer progresses in stages, there is an 
overall loss of DNA methylation, yet an 
hypermethylation of promoter dwelling 
CpG islands and an increase in incorrect 
histone methylation patterns. As a 
consequence of the latter, tumor 
suppressor genes may become silenced 
and retrotransposon based mobile 
interspersed repeats may become active, 
causing genome instability by inserting 
themselves in critical gene areas. Adapted 
from “M. Hirst and M. A. Marra, “The 
International Journal of Biochemistry 
Epigenetics and human disease” Int. J. 
Biochem., vol. 41, pp. 136–146, 2009.” 
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patients with depression [152]–[154] and hypomethylated on patients undergoing 
antidepressant treatment [155], [156]. The Nuclear Receptor Subfamily 3 Group C Member 
1 (NR3C1), which codes a glucocorticoid receptor, has inconsistent results, but has shown 
some slight tendency to be hypermethylated [157], [158] but there are also report of 
hypomethylation [159]. Currently, DNA hypomethylation in CpG dinucleotides, repetitive 
sequences, CpG islands hypermethylation, alongside general loss of methylation, is a well-
researched marker for cancer (Fig. 40) [160].  
 Non-coding areas of the genome are also linked between aberrant methylation and 
pathologies. LINE-1 hypomethylation has been present in many forms of cancer [78]. 
Tandem repeats, like Satellite α, a structurally critical centromeric heterochromatin located 
satellite DNA present in all human chromosomes,  similarly carry connections with cancer, 
with hypomethylation usually accompanying a bad prognosis [161], due to the fact 
hypomethylation of these areas causes genomic and structural instability. The presence of 
polymorphic tandem repeats in a gene’s promoter region has likewise been found to create 
variation in its methylation levels [162], but no link between their presence, number of 
repeats and size has been linked to pathologies yet. 
The possibility that nearly any DNA methylation deregulation, within or outside 
genes, be it coding, regulatory or structural expanses of DNA, can cause, be linked to or 
being a symptom of a wide range of pathologies will be something that will require further 
study to resolve, be it through the finding of methylation locations that are exempt of this 
issue or the finding of a way to offset variability caused by such cases, either through a larger 
battery of biomarkers or stronger internal standards. 
 
6.3.2. DNA Methylation variation with aging 
 
There are efforts to create a methodology that allows the age of a human to be derived 
from epigenetic information currently being made. Several genes already have been found 
to suffer hypomethylation at a stable rate with age, stable enough to create predictive models 
as accurate as 5 years [163]. Bocklandt et al. has determined 10 of such genes: Glycine 
Receptor Alpha 1, GLRA1; Neuronal Pentraxin 2, NPTX2; TSPY Like 5, TSPYL5; Solute 
Carrier Family 5 Member 7, SLC5A7; ATPase Phospholipid Transporting 8A2, ATP8A2; 
Leptin, LEP; Complexin 2, CPLX2;  Beta-1,3-Galactosyltransferase 6, B3GALT6; CUGBP 
Elav-like family member 6, CELF6; Potassium Two Pore Domain Channel Subfamily K 
Member 12; KCNK12. Those 10 genes were part of an 88 gene pool found to have 
methylation status changes related with age, most with varying rates across time (Table 8).  
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Table 8- Gene symbols of the 88 genes found to have methylation status changes related 
with age. Adapted from “S. Bocklandt et al., “Epigenetic Predictor of Age” PLoS One, 
2011.” 
 
 Hypermethylation  Hypomethylation 
KCNG3 IRF8 MCHR2 LRRC2 ASPA 
NPTX2 SKIP FAM19A4 NEF3 Bles03 
GREM1 CPLX2 RGC32 SPAG6 EDARADD 
VGF POU4F2 PCDHGB7 GCM2 TCEA2 
GRIA2 KLF14 FBLN2 IRXL1 ELN 
PDE4C GATA4 SLC15A3 NRN1 PGLYRP2 
FLJ42486 TBX20 PCDHGB4 SMPD3 LGP1 
ATP8A2 FLJ90650 LEP ZNF671 TOM1L1 
KCNK12 NEFH GRIA2 HOXB4 LAG3 
C10orf82 PCDH8 SHOX2 MOXD1 SLC14A1 
ZIC1 ZNF540 LOC349136 TCL1A CSNK1D 
BRUNOL6 ADRB1 KCNC1 KCNA5 ACSS2 
FLJ42486 ATP8A2 TSPYL5 
 
C9orf66 
ZNF667 VMP PNMA2 CENTD3 
TRIM58 GATA4 WNK2 HNRPL 
ZNF540 GLRA1 ADRA2C CDH5 
B3GALT6 KCNC3 SLC5A7 ABHD14A 
DCC ZNF154 GATA4 LTBR 
HTR7 LEP BARHL2 RENBP 
 
Even though DNA methylation suffers an overall small decline with age [30], these 
genes carry more variability that could diminish the methodology’s accuracy, being poor 
choices for postmortem interval biomarkers, and any potential biomarker should be checked 
for correlation with age, but they could be included in the methodology’s data retrieval 
process as they could provide more information about the victim’s age for virtually no added 
cost or time to the procedure, while being kept separate from the PMI assessment battery. 
The methylation status of the EDARADD, TOM1L1, and NPTX2 genes are linear with 
aging for five decades [163], being good candidates for this potential side addition to the 
methodology in the future. 
 
6.3.3. DNA Methylation variation due to the environment 
 
DNA methylation is a very resilient form of DNA regulation that undergoes strict 
regulation itself, but it is not an ironclad set of rules. DNA methylation is a plastic layer of 
regulation that can function both as a long-term response to environmental pressures and 
stresses in the context of generations of a specie or as short term response in the context of 
the life span of a single individual [164]. There are many, many forms of environmental and 
Strength of correlation with age High Low 
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behavioral pressures that can influence the methylation patterns, both at the global level, 
gene level and CpG location level.  
 
6.3.4. Validation 
 
For a novel forensic DNA analysis methodology to be accepted and validated it must 
go through rigorous studying and testing. To be accepted by the Federal Bureau of 
Investigation of the United States of America, a methodology requires extensive knowledge 
of the genetic biomarker in question, any species specificity that may change data between 
model organism and human testing; extensive studies for the methodology’s stability, 
sensitivity, reproducibility, precision and accuracy; have case-studies that validate the 
methodology’s theory and practice; if a methodology is PCR based it also must provide 
reaction conditions, testing for differential and preferential amplification, effects of 
multiplexing, assessment of appropriate controls and product detection studies [165]. 
Accordingly, the European Network of Forensic Science Institutes has its own guidelines 
for methodology validation [166]. It is a multiple step process, with many different 
requirements for different types of methodologies, be them human based, automatic based, 
qualitative or quantitative, etc, much harder to pass successfully if the methodology is brand 
new and underlying data and science has not yet been standardized by standards approving 
organizations like International Organization for Standardization, European Committee for 
Standardization or American Society for Testing and Materials. The process begins with a 
submission of the validation plan, which requires extensive information about the method, 
such as: 
• Measurement procedure, roughly outlying the basic premise of the 
methodology; 
• The biomarkers in study; 
• What property of the biomarker is measured and its measurement unit; 
• The range of the measurements; 
• The kind of samples the methodology accepts, including the type of matrixes; 
• The intended usage of the results, that for forensic methodologies usually 
being court reports and intelligence useful for the police force;  
• The precision of the methodology, with repeatability measured in RSDr5 % 
• Percentage of methodology bias and possible methodology selectiveness; 
• The robustness of the methodology and its uncertainty. 
• If it is a non-modified standards approving organizations protocol, modified 
protocol or new method; 
• If the methodology is quantitative, the extraction systems, the quantitation 
systems, the amplification systems, the reactional systems and the detection 
systems must pass, with provided sensitivity, stochastic and mixture studies, 
tests for repeatability, reproducibility, contamination assessment and tests 
with known samples. 
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Afterwards, a long process of peer-reviewing and standardization is conducted and after 
accreditation a methodology may be accepted as forensic evidence. The process requires 
large amounts of studies over enough independent laboratories to establish the foundation 
for the acceptance of the underlying scientific basis and large amounts of results that fall 
under the accepted ranges of reproducibility and repeatability. For a postmortem interval 
assessing methodology based on epigenetics to be created from the current availability of 
information as a starting point, a joint effort by many independent laboratories will be 
required to create such vast amounts of evidence required by the many international 
standards that try to regulate and intercommunicate forensic science, data and regulations. 
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7. Closing Thoughts 
 
Epigenetic information has incredibly stable biomarkers throughout the entire life of 
an organism, and, as more recent studies have shown, epigenetic information is also 
incredibly stable after death. Both dried blood spots [147] and brain tissue [139]–[141] 
provide reliable, stable and pristine methylation data when stored at even room temperatures, 
even if the DNA itself where it is stored becomes very degraded and hard to work with [143].  
 Yet, even with the preliminary studies showing that its stability is suited for the for 
this kind of forensic usage, there are many variables that need to be accounted for before the 
work of creating a battery viable for PMI assessment. Firstly, the biomarkers used need to 
be thoroughly studied, not only for normal methylation levels in all stages of life and 
degradation rates postmortem, but also for possible changes it can suffer throughout an 
organism’s life, as DNA methylation changes as a response to environmental stimuli, 
changes that are enough to even distinguish monozygotic twins [23], [24]. Ideally, 
biomarkers should be chosen taking in consideration what kind of response they produce to 
batches of stimuli, to make sure any major variation due to lifestyle choices, response to 
local pollution levels, etc, is kept to the minimal amount of biomarkers in the battery,  as 
well as choosing biomarkers that are also affected by the least amount of these pressures. 
LINE-1 are preliminary prime candidates for PMI assessment, as they are large, spread out 
sections of DNA kept under high amounts of methylation and regulation, not directly linked 
to any protein that could function as a response to environmental stimuli. Other satellite 
DNA, like Alu, should also be the subject of scrutiny due to the striking similarities between 
itself and LINE-1. Individual gene biomarkers, on the other hand, will be heavily reliant on 
a case-by-case study, and only further study will show more candidates for a possible battery 
of biomarkers. In the terms of internal standards, the battery possesses global methylation as 
the normalization factor between samples and a large array of housekeeping genes to be used 
as negative controls. The battery could also incorporate extra biomarkers outside of the core 
PMI assessing battery like the EDARADD, TOM1L1 and NPTX2 genes, whose methylation 
levels have been linked to biological passage of time in a linear way, possibly adding age of 
the sample donor to the information the methodology can provide.  
DNA availability is a big variable as well. Upon finding a body, there will be no 
shortage of organic matrixes to obtain DNA from, albeit its condition may be quite degraded 
if the body itself is already in late stages of decomposition. Blood splatters that may be 
spread around the crime scene where the victim was originally assaulted but no body being 
present however, provide much lower quantities of DNA and may be all that it may be 
available. Albeit blood splatters do not confirm death and may give different postmortem 
intervals after a possible body recovery, they do help to cement the time at which the 
confrontation may have occurred and if the death was caused during it, thus strengthening 
the timeline of events, and subsequently the investigation. Thus, it would be highly 
recommended that the techniques chosen to perform the PMI assessments are capable of 
handling the low quantities of DNA usually present in forensics whenever a body has not 
65 
 
yet been found, in order for the methodology to be able to provide the most amount of 
information in the largest amounts of cases in a standard form. The discrepancy between 
postmortem intervals between a retrieved corpse and a blood splatter obtained from a crime 
scene can be interpreted in various ways: if the PMIs don’t match, there was an assault or 
struggle at the location of the blood splatters but the death did not occur during it, and the 
larger the gap, the more information about the case may be missing; if the PMI of the blood 
splatter matches when a suspect was seen at the scene but the PMI of the corpse doesn’t, 
with enough of a gap, the suspect might possess an alibi for that time, or the victim was 
abandoned and emergency services were not contacted, denoting criminal intent; if the PMIs 
match but the body and samples were not recovered at the same location, it can be inferred 
that the body was moved postmortem, and both locations become tightly linked. As any 
information during investigation is precious, this take on the methodology is highly 
recommended. 
 While the amount of postmortem methylation data and its stability gathered by the 
scientific community is plentiful, the study of the key rates of degradation, both globally and 
of individual loci, are far and few, studies of methylation using old samples under poor 
storage conditions are extremely rare, and the forensic study of this particular use of 
methylation is in its early stages, but the preliminary research and the research done in other 
areas of expertise point towards a good prognosis to the epigenetic assessment of postmortem 
intervals. 
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